02010R0037 — EN — 29.09.2018 — 035.001 — 1

This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B COMMISSION REGULATION (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (Text with EEA relevance) (OJ L 15, 20.1.2010, p. 1)

Amended by:

Official Journal

No page date ►M1 Commission Regulation (EU) No 758/2010 of 24 August 2010 L 223 37 25.8.2010 ►M2 Commission Regulation (EU) No 759/2010 of 24 August 2010 L 223 39 25.8.2010 ►M3 Commission Regulation (EU) No 761/2010 of 25 August 2010 L 224 1 26.8.2010 ►M4 Commission Regulation (EU) No 890/2010 of 8 October 2010 L 266 1 9.10.2010 ►M5 Commission Regulation (EU) No 914/2010 of 12 October 2010 L 269 5 13.10.2010 ►M6 Commission Regulation (EU) No 362/2011 of 13 April 2011 L 100 26 14.4.2011 ►M7 Commission Regulation (EU) No 363/2011 of 13 April 2011 L 100 28 14.4.2011 ►M8 Commission Implementing Regulation (EU) No 84/2012 of 1 L 30 1 2.2.2012 February 2012 ►M9 Commission Implementing Regulation (EU) No 85/2012 of 1 L 30 4 2.2.2012 February 2012 ►M10 Commission Implementing Regulation (EU) No 86/2012 of 1 L 30 6 2.2.2012 February 2012 ►M11 Commission Implementing Regulation (EU) No 107/2012 of 8 L 36 25 9.2.2012 February 2012 ►M12 Commission Implementing Regulation (EU) No 122/2012 of 13 L 40 2 14.2.2012 February 2012 ►M13 Commission Implementing Regulation (EU) No 123/2012 of 13 L 40 4 14.2.2012 February 2012 ►M14 Commission Implementing Regulation (EU) No 201/2012 of 8 L 71 37 9.3.2012 March 2012 ►M15 Commission Implementing Regulation (EU) No 202/2012 of 8 L 71 40 9.3.2012 March 2012 ►M16 Commission Implementing Regulation (EU) No 221/2012 of 14 L 75 7 15.3.2012 March 2012 ►M17 Commission Implementing Regulation (EU) No 222/2012 of 14 L 75 10 15.3.2012 March 2012 ►M18 Commission Implementing Regulation (EU) No 436/2012 of 23 L 134 10 24.5.2012 May 2012 ►M19 Commission Implementing Regulation (EU) No 466/2012 of 1 L 143 2 2.6.2012 June 2012 ►M20 Commission Implementing Regulation (EU) No 1161/2012 of 7 L 336 14 8.12.2012 December 2012 02010R0037 — EN — 29.09.2018 — 035.001 — 2

►M21 Commission Implementing Regulation (EU) No 1186/2012 of 11 L 338 20 12.12.2012 December 2012 ►M22 Commission Implementing Regulation (EU) No 1191/2012 of 12 L 340 35 13.12.2012 December 2012 ►M23 Commission Implementing Regulation (EU) No 59/2013 of 23 L 21 21 24.1.2013 January 2013 ►M24 Commission Implementing Regulation (EU) No 115/2013 of 8 L 38 11 9.2.2013 February 2013 ►M25 Commission Implementing Regulation (EU) No 116/2013 of 8 L 38 14 9.2.2013 February 2013 ►M26 Commission Implementing Regulation (EU) No 394/2013 of 29 L 118 17 30.4.2013 April 2013 ►M27 Commission Implementing Regulation (EU) No 406/2013 of 2 L 121 42 3.5.2013 May 2013 ►M28 Commission Implementing Regulation (EU) No 489/2013 of 27 L 141 4 28.5.2013 May 2013 ►M29 Commission Implementing Regulation (EU) No 1056/2013 of 29 L 288 60 30.10.2013 October 2013 ►M30 Commission Implementing Regulation (EU) No 1057/2013 of 29 L 288 63 30.10.2013 October 2013 ►M31 Commission Implementing Regulation (EU) No 1235/2013 of 2 L 322 21 3.12.2013 December 2013 ►M32 Commission Implementing Regulation (EU) No 19/2014 of 10 L 8 18 11.1.2014 January 2014 ►M33 Commission Implementing Regulation (EU) No 20/2014 of 10 L 8 20 11.1.2014 January 2014 ►M34 Commission Implementing Regulation (EU) No 200/2014 of 3 L 62 8 4.3.2014 March 2014 ►M35 Commission Implementing Regulation (EU) No 201/2014 of 3 L 62 10 4.3.2014 March 2014 ►M36 Commission Implementing Regulation (EU) No 418/2014 of 24 L 124 19 25.4.2014 April 2014 ►M37 Commission Implementing Regulation (EU) No 676/2014 of 19 L 180 5 20.6.2014 June 2014 ►M38 Commission Implementing Regulation (EU) No 677/2014 of 19 L 180 8 20.6.2014 June 2014 ►M39 Commission Implementing Regulation (EU) No 681/2014 of 20 L 182 11 21.6.2014 June 2014 ►M40 Commission Implementing Regulation (EU) No 682/2014 of 20 L 182 14 21.6.2014 June 2014 ►M41 Commission Implementing Regulation (EU) No 683/2014 of 20 L 182 17 21.6.2014 June 2014 ►M42 Commission Implementing Regulation (EU) No 967/2014 of 12 L 272 3 13.9.2014 September 2014 ►M43 Commission Implementing Regulation (EU) No 1277/2014 of 1 L 346 23 2.12.2014 December 2014 ►M44 Commission Implementing Regulation (EU) No 1359/2014 of 18 L 365 103 19.12.2014 December 2014 ►M45 Commission Implementing Regulation (EU) No 1390/2014 of 19 L 369 65 24.12.2014 December 2014 ►M46 Commission Implementing Regulation (EU) 2015/149 of 30 L 26 7 31.1.2015 January 2015 ►M47 Commission Implementing Regulation (EU) 2015/150 of 30 L 26 10 31.1.2015 January 2015 ►M48 Commission Implementing Regulation (EU) 2015/151 of 30 L 26 13 31.1.2015 January 2015 ►M49 Commission Implementing Regulation (EU) 2015/152 of 30 L 26 16 31.1.2015 January 2015 02010R0037 — EN — 29.09.2018 — 035.001 — 3

►M50 Commission Implementing Regulation (EU) 2015/394 of 10 L 66 1 11.3.2015 March 2015 ►M51 Commission Implementing Regulation (EU) 2015/446 of 17 L 74 18 18.3.2015 March 2015 ►M52 Commission Implementing Regulation (EU) 2015/1078 of 3 July 2015 L 175 5 4.7.2015 ►M53 Commission Implementing Regulation (EU) 2015/1079 of 3 July 2015 L 175 8 4.7.2015 ►M54 Commission Implementing Regulation (EU) 2015/1080 of 3 July 2015 L 175 11 4.7.2015 ►M55 Commission Implementing Regulation (EU) 2015/1308 of 29 July 2015 L 200 11 30.7.2015 ►M56 Commission Implementing Regulation (EU) 2015/1491 of 3 September L 231 7 4.9.2015 2015 ►M57 Commission Implementing Regulation (EU) 2015/1492 of 3 September L 231 10 4.9.2015 2015 ►M58 Commission Implementing Regulation (EU) 2015/1820 of 9 October L 265 1 10.10.2015 2015 ►M59 Commission Implementing Regulation (EU) 2015/2062 of 17 L 301 7 18.11.2015 November 2015 ►M60 Commission Implementing Regulation (EU) 2016/129 of 1 February L 25 44 2.2.2016 2016 ►M61 Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 L 58 35 4.3.2016 ►M62 Commission Implementing Regulation (EU) 2016/312 of 4 March 2016 L 60 3 5.3.2016 ►M63 Commission Implementing Regulation (EU) 2016/576 of 14 April 2016 L 99 1 15.4.2016 ►M64 Commission Implementing Regulation (EU) 2016/710 of 12 May 2016 L 125 6 13.5.2016 ►M65 Commission Implementing Regulation (EU) 2016/885 of 3 June 2016 L 148 1 4.6.2016 ►M66 Commission Implementing Regulation (EU) 2016/1444 of 31 August L 235 8 1.9.2016 2016 ►M67 Commission Implementing Regulation (EU) 2016/1834 of 17 October L 280 22 18.10.2016 2016 ►M68 Commission Implementing Regulation (EU) 2016/2045 of 23 L 318 3 24.11.2016 November 2016 ►M69 Commission Implementing Regulation (EU) 2016/2074 of 25 L 320 29 26.11.2016 November 2016 ►M70 Commission Implementing Regulation (EU) 2017/201 of 6 February L 32 17 7.2.2017 2017 ►M71 Commission Implementing Regulation (EU) 2017/1558 of 14 L 237 67 15.9.2017 September 2017 ►M72 Commission Implementing Regulation (EU) 2017/1559 of 14 L 237 69 15.9.2017 September 2017 ►M73 Commission Implementing Regulation (EU) 2018/520 of 28 March L 87 9 3.4.2018 2018 ►M74 Commission Implementing Regulation (EU) 2018/523 of 28 March L 88 1 4.4.2018 2018 ►M75 Commission Implementing Regulation (EU) 2018/721 of 16 May 2018 L 122 5 17.5.2018 ►M76 Commission Implementing Regulation (EU) 2018/722 of 16 May 2018 L 122 8 17.5.2018 ►M77 Commission Implementing Regulation (EU) 2018/1076 of 30 July 2018 L 194 41 31.7.2018

Corrected by:

►C1 Corrigendum, OJ L 293, 11.11.2010, p. 72 (37/2010) 02010R0037 — EN — 29.09.2018 — 035.001 — 4

▼B COMMISSION REGULATION (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (Text with EEA relevance)

Article 1

Pharmacologically active substances and their classification regarding maximum residue limits are set out in the Annex.

Article 2

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union. This Regulation shall be binding in its entirety and directly applicable in all Member States. 02010R0037 — EN — 29.09.2018 — 035.001 — 5

▼B ANNEX

Pharmacologically active substances and their classification regarding maximum residue limits (MRL)

Table 1

Allowed substances

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Abamectin Avermectin B1a Bovine 10 μg/kg Fat NO ENTRY Antiparasitic agents/ 20 μg/kg Liver Agents acting against endo- and ectoparasites

Ovine 20 μg/kg Muscle Not for use in 50 μg/kg Fat animals from which 25 μg/kg Liver milk is produced for 20 μg/kg Kidney human consumption.

Absinthium NOT All food No MRL NOT NO ENTRY NO ENTRY extract APPLICABLE producing required APPLICABLE species

Acetyl cysteine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Acetylme­ NOT All food No MRL NOT NO ENTRY NO ENTRY thionine APPLICABLE producing required APPLICABLE species

Acetylsalicylic NOT All food No MRL NOT Not for use in NO ENTRY acid APPLICABLE producing required APPLICABLE animals from which species except milk or eggs are fin fish produced for human consumption.

Acetylsalicylic NOT All food No MRL NOT Not for use in NO ENTRY acid DL-lysine APPLICABLE producing required APPLICABLE animals from which species except milk or eggs are fin fish produced for human consumption.

Adenosine and NOT All food No MRL NOT NO ENTRY NO ENTRY its 5’-mono-, 5’- APPLICABLE producing required APPLICABLE di-and 5’ trip­ species hosphates

Adonis vernalis NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according 02010R0037 — EN — 29.09.2018 — 035.001 — 6

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only.

Aesculus NOT All food No MRL NOT For use in homeo­ NO ENTRY hippocastanum APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per ten only.

Agnus castus NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Ailanthus NOT All food No MRL NOT For use in homeo­ NO ENTRY altissima APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Alanine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M72

Alarelin NOT All food-pro­ No MRL NOT NO ENTRY Agents acting on APPLICABLE ducing required APPLICABLE the reproductive species system

▼B

Albendazole Sum of alben­ All ruminants 100 μg/kg Muscle NO ENTRY Antiparasitic agents/ dazole 100 μg/kg Fat Agents against sulphoxide, 1 000 μg/kg Liver endoparasites albendazole 500 μg/kg Kidney sulphone, and 100 μg/kg Milk albendazole 2- amino sulphone, expressed as albendazole 02010R0037 — EN — 29.09.2018 — 035.001 — 7

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Albendazole Sum of alben­ Bovine, ovine 100 μg/kg Muscle NO ENTRY Antiparasitic agents/ oxide dazole oxide, 100 μg/kg Fat Agents against albendazole 1 000 μg/kg Liver endoparasites sulphone, and 500 μg/kg Kidney albendazole 2- 100 μg/kg Milk amino sulphone, expressed as albendazole

Alfacalcidol NOT Bovine No MRL NOT For parturient cows NO ENTRY APPLICABLE required APPLICABLE only.

Alfaprostol NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE porcine, required APPLICABLE rabbit, Equidae

Allantoin NOT All food-pro­ No MRL NOT For topical use only. NO ENTRY APPLICABLE ducing required APPLICABLE species

Allium cepa NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Aloe vera gel NOT All food No MRL NOT For topical use only. NO ENTRY and whole leaf APPLICABLE producing required APPLICABLE extract of Aloe species vera

Aloes, Barbados NOT All food No MRL NOT NO ENTRY NO ENTRY and Capae, their APPLICABLE producing required APPLICABLE standardised dry species extract and preparations thereof

Alphacyper­ Bovine, ovine 20 μg/kg Muscle For milk MRL Antiparasitic agents/ methrin (sum of 200 μg/kg Fat further provisions in Agents against isomers) 20 μg/kg Liver Commission ectoparasites 20 μg/kg Kidney Directive 98/82/EC 20 μg/kg Milk are to be observed. 02010R0037 — EN — 29.09.2018 — 035.001 — 8

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

▼M9 Altrenogest Altrenogest Porcine 4 μg/kg Skin and fat Only for Agents acting on zootechnical use the reproductive 2 μg/kg Liver and in accordance system with the provisions Equidae 4 μg/kg Fat of Directive 96/22/ EC 4 μg/kg Liver

▼B Aluminium NOT All food No MRL NOT NO ENTRY NO ENTRY distearate APPLICABLE producing required APPLICABLE species

Aluminium NOT All food No MRL NOT NO ENTRY NO ENTRY hydroxide APPLICABLE producing required APPLICABLE species

Aluminium NOT All food No MRL NOT NO ENTRY NO ENTRY hydroxide APPLICABLE producing required APPLICABLE acetate species

Aluminium NOT All food No MRL NOT NO ENTRY NO ENTRY monostearate APPLICABLE producing required APPLICABLE species

Aluminium NOT All food No MRL NOT NO ENTRY NO ENTRY phosphate APPLICABLE producing required APPLICABLE species

▼M69

Aluminium Salicylic acid Bovine, 200 μg/kg Muscle NO ENTRY Antidiarrheal and salicylate, basic caprine, 500 μg/kg Fat intestinal Equidae, 1 500 μg/kg Liver anti-inflammatory rabbit 1 500 μg/kg Kidney agents

Bovine, 9 μg/kg Milk caprine, Equidae

NOT All food No MRL NOT For topical use only APPLICABLE producing required APPLICABLE species except bovine, caprine, Equidae, rabbit and fin fish

▼B

Aluminium tris­ NOT All food No MRL NOT NO ENTRY NO ENTRY tearate APPLICABLE producing required APPLICABLE species

2-Aminoethanol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

2-Aminoethanol NOT All food No MRL NOT NO ENTRY NO ENTRY glucuronate APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 9

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

2-Aminoethyl NOT All food No MRL NOT NO ENTRY NO ENTRY dihydro­ APPLICABLE producing required APPLICABLE genphosphate species

Amitraz Sum of Bovine 200 μg/kg Fat NO ENTRY Antiparasitic agents/ and all meta­ 200 μg/kg Liver Agents against bolites 200 μg/kg Kidney ectoparasites containing the 10 μg/kg Milk 2,4-DMA moiety, expressed as amitraz Ovine 400 μg/kg Fat 100 μg/kg Liver 200 μg/kg Kidney 10 μg/kg Milk

Caprine 200 μg/kg Fat 100 μg/kg Liver 200 μg/kg Kidney 10 μg/kg Milk

Porcine 400 μg/kg Skin and fat 200 μg/kg Liver 200 μg/kg Kidney

Bees 200 μg/kg Honey

Ammonium NOT All food No MRL NOT NO ENTRY NO ENTRY chloride APPLICABLE producing required APPLICABLE species

Ammonium NOT All food-pro­ No MRL NOT NO ENTRY NO ENTRY lauryl sulphate APPLICABLE ducing required APPLICABLE species

Ammonium NOT All food No MRL NOT NO ENTRY NO ENTRY sulfate APPLICABLE producing required APPLICABLE species

Amoxicillin Amoxicillin All food 50 μg/kg Muscle For fin fish the Anti-infectious producing 50 μg/kg Fat muscle MRL relates agents/Antibiotics species 50 μg/kg Liver to ‘muscle and 50 μg/kg Kidney skin in natural 4 μg/kg Milk proportions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. 02010R0037 — EN — 29.09.2018 — 035.001 — 10

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Not for use in animals from which eggs are pro- duced for human consumption.

Ampicillin Ampicillin All food 50 μg/kg Muscle For fin fish the Anti-infectious producing 50 μg/kg Fat muscle MRL relates agents/Antibiotics species 50 μg/kg Liver to ‘muscle and 50 μg/kg Kidney skin in natural 4 μg/kg Milk proportions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are pro- duced for human consumption.

Amprolium NOT Poultry No MRL NOT For oral use only. NO ENTRY APPLICABLE required APPLICABLE

Angelicae radix NOT All food No MRL NOT NO ENTRY NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE species

Anisi aethe­ NOT All food No MRL NOT NO ENTRY NO ENTRY roleum APPLICABLE producing required APPLICABLE species

Anisi stellati NOT All food No MRL NOT NO ENTRY NO ENTRY fructus, stan­ APPLICABLE producing required APPLICABLE dardised extracts species and preparations thereof

Apocynum NOT All food No MRL NOT For use in homeo­ NO ENTRY cannabinum APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only. For oral use only. 02010R0037 — EN — 29.09.2018 — 035.001 — 11

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Apramycin Apramycin Bovine 1 000 μg/kg Muscle Not for use in Anti-infectious 1 000 μg/kg Fat animals from which agents/Antibiotics 10 000 μg/kg Liver milk is produced for 20 000 μg/kg Kidney human consump- tion.

NOT Ovine, No MRL NOT For oral use only. APPLICABLE porcine, required APPLICABLE Not for use in chicken, animals from which rabbit milk or eggs are produced for human consump- tion.

Aqua levici NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias only.

Arginine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Arnica montana NOT All food No MRL NOT For topical use only. NO ENTRY (arnicae flos APPLICABLE producing required APPLICABLE and arnicae species planta tota)

Arnicae radix NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only.

Artemisia NOT All food No MRL NOT For use in homeo­ NO ENTRY abrotanum APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Asparagine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 12

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Aspartic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Atropa NOT All food No MRL NOT For use in homeo­ NO ENTRY belladonna APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only.

Atropine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Avilamycin Dichloroisoe­ Porcine, 50 μg/kg Muscle For porcine and Anti-infectious verninic acid poultry, rabbit 100 μg/kg Fat poultry species this agents/Antibiotics 300 μg/kg Liver MRL relates to 200 μg/kg Kidney ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human consumption.

Azagly- NOT Salmonidae No MRL NOT Not for use in fish NO ENTRY APPLICABLE required APPLICABLE from which eggs are produced for human consumption.

▼M18

Azamethiphos NOT Fin fish No MRL NOT NO ENTRY Antiparasitic agents/ APPLICABLE required APPLICABLE Agents against ectoparasites

▼B

Azaperone Sum of Porcine 100 μg/kg Muscle NO ENTRY Agents acting on azaperone and 100 μg/kg Skin and fat the nervous system/ azaperol 100 μg/kg Liver Agents acting on 100 μg/kg Kidney the central nervous system

Bacitracin Sum of Bovine 100 μg/kg Milk NO ENTRY Anti-infectious bacitracin A, agents/Antibiotics bacitracin B, and bacitracin C Rabbit 150 μg/kg Muscle 150 μg/kg Fat 150 μg/kg Liver 150 μg/kg Kidney

NOT Bovine No MRL NOT For intramammary APPLICABLE required for APPLICABLE use in lactating all tissues cows only. except milk. 02010R0037 — EN — 29.09.2018 — 035.001 — 13

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Balsamum peru­ NOT All food No MRL NOT For topical use only. NO ENTRY vianum APPLICABLE producing required APPLICABLE species

Baquiloprim Baquiloprim Bovine 10 μg/kg Fat NO ENTRY Anti-infectious 300 μg/kg Liver agents/Chemotheu­ 150 μg/kg Kidney rapeutics 30 μg/kg Milk

Porcine 40 μg/kg Skin and fat 50 μg/kg Liver 50 μg/kg Kidney

▼M51

Barium selenate NOT All food No MRL NOT Not for administra­ Alimentary tract APPLICABLE producing required APPLICABLE tion by injection and metabolism/ species mineral supplements

▼B

Beclomethasone NOT Equidae No MRL NOT For inhalation use NO ENTRY dipropionate APPLICABLE required APPLICABLE only.

Bellis perennis NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Benzalkonium NOT All food No MRL NOT For use as an NO ENTRY chloride APPLICABLE producing required APPLICABLE excipient at concen­ species trations up to 0,05 % only.

Benzocaine NOT All food No MRL NOT For use as local NO ENTRY APPLICABLE producing required APPLICABLE anaesthetic only. species

Salmonidae No MRL NOT NO ENTRY required APPLICABLE

Benzyl alcohol NOT All food No MRL NOT For use as excipient. NO ENTRY APPLICABLE producing required APPLICABLE species

Benzyl benzoate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 14

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Benzyl p-hy­ NOT All food No MRL NOT NO ENTRY NO ENTRY droxybenzoate APPLICABLE producing required APPLICABLE species

Benzylpenicillin Benzylpenicillin All food 50 μg/kg Muscle For fin fish the Anti-infectious producing 50 μg/kg Fat muscle MRL relates agents/Antibiotics species 50 μg/kg Liver to ‘muscle and skin 50 μg/kg Kidney in natural pro- 4 μg/kg Milk portions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human con- sumption.

Betaine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Betaine glucu­ NOT All food No MRL NOT NO ENTRY NO ENTRY ronate APPLICABLE producing required APPLICABLE species

Betamethasone Betamethasone Bovine, 0,75 μg/kg Muscle NO ENTRY Corticoides/Gluco­ porcine 2,0 μg/kg Liver corticoides 0,75 μg/kg Kidney

Bovine 0,3 μg/kg Milk

Biotin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Bismuth subcar­ NOT All food No MRL NOT For oral use only. NO ENTRY bonate APPLICABLE producing required APPLICABLE species

Bismuth NOT All food No MRL NOT For oral use only. NO ENTRY subgallate APPLICABLE producing required APPLICABLE species

Bismuth NOT All food No MRL NOT For oral use only. NO ENTRY subnitrate APPLICABLE producing required APPLICABLE species

Bovine No MRL NOT For intramammary NO ENTRY required APPLICABLE use only. 02010R0037 — EN — 29.09.2018 — 035.001 — 15

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Bismuth NOT All food No MRL NOT For oral use only. NO ENTRY subsalicylate APPLICABLE producing required APPLICABLE species

Bituminosul­ NOT All No MRL NOT For topical use only. NO ENTRY fonates, APPLICABLE mammalian required APPLICABLE ammonium and food sodium salts producing species

Boldo folium NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Boric acid and NOT All food No MRL NOT NO ENTRY NO ENTRY borates APPLICABLE producing required APPLICABLE species

▼M71

Bromelain NOT Porcine No MRL NOT NO ENTRY Antidiarrheal agents APPLICABLE required APPLICABLE

▼B

Bromhexine NOT Bovine, No MRL NOT Not for use in NO ENTRY APPLICABLE porcine, required APPLICABLE animals from which poultry milk or eggs are produced for human consumption.

Bromide, NOT All food No MRL NOT NO ENTRY NO ENTRY potassium salt APPLICABLE producing required APPLICABLE species

Bromide, NOT All- No MRL NOT For topical use only. NO ENTRY sodium salt APPLICABLE mammalian required APPLICABLE food-pro­ ducing species

Bronopol NOT Fin fish No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

Brotizolam NOT Bovine No MRL NOT For therapeutic uses NO ENTRY APPLICABLE required APPLICABLE only.

Buserelin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M33

Butafosfan NOT All No MRL NOT NO ENTRY Alimentary tract APPLICABLE mammalian required APPLICABLE and metabolism/ food mineral producing supplements species

▼B

n-Butane NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 16

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

n-Butanol NOT All food No MRL NOT For use as excipient. NO ENTRY APPLICABLE producing required APPLICABLE species

Butorphanole NOT Equidae No MRL NOT For intravenous ad­ NO ENTRY tartrate APPLICABLE required APPLICABLE ministration only.

Butyl NOT All food No MRL NOT NO ENTRY NO ENTRY 4-hydroxy­ APPLICABLE producing required APPLICABLE benzoate species

Butylscopola­ NOT All food No MRL NOT NO ENTRY NO ENTRY minium bromide APPLICABLE producing required APPLICABLE species

▼M38

Cabergoline Cabergoline Bovine 0,10 μg/kg Fat NO ENTRY Prolactin inhibitor

0,25 μg/kg Liver 0,50 μg/kg Kidney 0,15 μg/kg Muscle 0,10 μg/kg Milk

▼B

Caffeine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Calcium acetate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY aspartate APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY benzoate APPLICABLE producing required APPLICABLE species

Calcium borog­ NOT All food No MRL NOT NO ENTRY NO ENTRY luconate APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY carbonate APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY chloride APPLICABLE producing required APPLICABLE species

Calcium citrate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Calcium gluco­ NOT All food No MRL NOT NO ENTRY NO ENTRY heptonate APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 17

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY gluconate APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY glucono gluco­ APPLICABLE producing required APPLICABLE heptonate species

Calcium gluco­ NOT All food No MRL NOT NO ENTRY NO ENTRY nolactate APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY glutamate APPLICABLE producing required APPLICABLE species

Calcium glyce­ NOT All food No MRL NOT NO ENTRY NO ENTRY rophosphate APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY hydroxide APPLICABLE producing required APPLICABLE species

Calcium hypo­ NOT All food No MRL NOT NO ENTRY NO ENTRY phosphite APPLICABLE producing required APPLICABLE species

Calcium malate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Calcium oxide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY pantothenate APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY phosphate APPLICABLE producing required APPLICABLE species

Calcium poly­ NOT All food No MRL NOT NO ENTRY NO ENTRY phosphates APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY propionate APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 18

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Calcium silicate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Calcium stearate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Calcium NOT All food No MRL NOT NO ENTRY NO ENTRY sulphate APPLICABLE producing required APPLICABLE species

Calendula NOT All food No MRL NOT For use in homeo­ NO ENTRY officinalis APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only.

Calendulae flos NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Camphor NOT All food No MRL NOT External use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Camphora NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per hundred only.

Capsici fructus NOT All food No MRL NOT NO ENTRY NO ENTRY acer APPLICABLE producing required APPLICABLE species

Carazolol Carazolol Bovine 5 μg/kg Muscle NO ENTRY Agents acting on 5 μg/kg Fat the nervous system/ 15 μg/kg Liver Agents acting on 15 μg/kg Kidney the autonomic 1 μg/kg Milk nervous system

Porcine 5 μg/kg Muscle 5 μg/kg Skin and fat 25 μg/kg Liver 25 μg/kg Kidney 02010R0037 — EN — 29.09.2018 — 035.001 — 19

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Carbasalate NOT All food No MRL NOT Not for use in NO ENTRY calcium APPLICABLE producing required APPLICABLE animals from which species except milk or eggs are fin fish produced for human consump- tion.

Carbetocin NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Cardamon NOT All food No MRL NOT NO ENTRY NO ENTRY extract APPLICABLE producing required APPLICABLE species

Cardiospermum NOT All food No MRL NOT For use in homeo­ NO ENTRY halicacabum APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Carlinae radix NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Carnitine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Carprofen Sum of Bovine, 500 μg/kg Muscle NO ENTRY Anti-inflammatory carprofen and Equidae 1 000 μg/kg Fat agents/Nonsteroidal carprofen glucu­ 1 000 μg/kg Liver anti-inflammatory ronide conjugate 1 000 μg/kg Kidney agents

NOT Bovine No MRL NOT APPLICABLE required for APPLICABLE milk

Carvi aethe­ NOT All food No MRL NOT NO ENTRY NO ENTRY roleum APPLICABLE producing required APPLICABLE species

Caryophylli NOT All food No MRL NOT NO ENTRY NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 20

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Cefacetrile Cefacetrile Bovine 125 μg/kg Milk For intramammary Anti-infectious use only. agents/Antibiotics

NOT Bovine No MRL NOT APPLICABLE required for APPLICABLE all tissues except milk.

Cefalexin Cefalexin Bovine 200 μg/kg Muscle NO ENTRY Anti-infectious 200 μg/kg Fat agents/Antibiotics 200 μg/kg Liver 1 000 μg/kg Kidney 100 μg/kg Milk

Cefalonium Cefalonium Bovine 20 μg/kg Milk For intramammary Anti-infectious use and eye agents/Antibiotics treatment only. NOT Bovine No MRL NOT APPLICABLE required for APPLICABLE all tissues except milk.

Cefapirin Sum of Bovine 50 μg/kg Muscle NO ENTRY Anti-infectious cephapirin and 50 μg/kg Fat agents/Antibiotics desacetylcep­ 100 μg/kg Kidney hapirin 60 μg/kg Milk

Cefazolin Cefazolin Bovine, 50 μg/kg Milk NO ENTRY Anti-infectious ovine, caprine agents/Antibiotics

NOT Bovine, No MRL NOT For intramammary APPLICABLE ovine, caprine required for APPLICABLE use, except if the all tissues udder may be used except milk. as food for human consumption.

Cefoperazone Cefoperazone Bovine 50 μg/kg Milk For intramammary Anti-infectious use in lactating agents/Antibiotics cows only. NOT Bovine No MRL NOT APPLICABLE required for APPLICABLE all tissues except milk.

Cefquinome Cefquinome Bovine, 50 μg/kg Muscle For porcine species Anti-infectious porcine, 50 μg/kg Fat the fat MRL relates agents/Antibiotics Equidae 100 μg/kg Liver to ‘skin and fat in 200 μg/kg Kidney natural proportions’.

Bovine 20 μg/kg Milk

Ceftiofur Sum of all All 1 000 μg/kg Muscle For porcine species Anti-infectious residues mammalian 2 000 μg/kg Fat the fat MRL relates agents/Antibiotics retaining the food 2 000 μg/kg Liver to ‘skin and fat in betalactam producing 6 000 μg/kg Kidney natural proportions’. structure species 100 μg/kg Milk expressed as desfuroylcef­ tiofur 02010R0037 — EN — 29.09.2018 — 035.001 — 21

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Centellae NOT All food No MRL NOT For topical use only. NO ENTRY asiaticae APPLICABLE producing required APPLICABLE extractum species

Cetostearyl NOT All food No MRL NOT NO ENTRY NO ENTRY alcohol APPLICABLE producing required APPLICABLE species

Cetrimide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Chlorhexidine NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Chlormadinone Chlormadi- Bovine 4 μg/kg Fat For zootechnical use Agents acting on none 2 μg/kg Liver only. the reproductive 2,5 μg/kg Milk system

Chlorocresol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M32

Chloroform NOT All No MRL NOT Only to be used as NO ENTRY APPLICABLE mammalian required APPLICABLE an excipient in food vaccines and only at producing concentrations not species exceeding 1 % w/v and total doses not exceeding 20 mg per animal.

▼B

Chlorphenamine NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Chlortetracy- Sum of parent All food-pro­ 100 μg/kg Muscle For fin fish the Anti-infectious cline drug and its 4- ducing 300 μg/kg Liver muscle MRL relates agents/Antibiotics epimer species 600 μg/kg Kidney to ‘muscle and skin 100 μg/kg Milk in natural propor­ 200 μg/kg Eggs tions’. MRLs for liver and kidney do not apply to fin fish.

Choline NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Chrysanthemi NOT All food No MRL NOT For topical use only. NO ENTRY cinerariifolii APPLICABLE producing required APPLICABLE flos species

Chymotrypsin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 22

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Cimicifugae NOT All food No MRL NOT Not for use in NO ENTRY racemosae APPLICABLE producing required APPLICABLE animals from which rhizoma species milk is produced for human con- sumption.

Cinchonae NOT All food No MRL NOT NO ENTRY NO ENTRY cortex, stan­ APPLICABLE producing required APPLICABLE dardised extracts species and preparations thereof

Cinnamomi NOT All food No MRL NOT NO ENTRY NO ENTRY cassiae aethe­ APPLICABLE producing required APPLICABLE roleum species

Cinnamomi NOT All food No MRL NOT NO ENTRY NO ENTRY cassiae cortex, APPLICABLE producing required APPLICABLE standardised species extracts and preparations thereof

Cinnamomi NOT All food No MRL NOT NO ENTRY NO ENTRY ceylanici aethe­ APPLICABLE producing required APPLICABLE roleum species

Cinnamomi NOT All food No MRL NOT NO ENTRY NO ENTRY ceylanici cortex, APPLICABLE producing required APPLICABLE standardised species extracts and preparations thereof

Citri aethe­ NOT All food No MRL NOT NO ENTRY NO ENTRY roleum APPLICABLE producing required APPLICABLE species

Citronellae NOT All food No MRL NOT NO ENTRY NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE species

Citrulline NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Clavulanic acid Clavulanic acid Bovine, 100 μg/kg Muscle For porcine species Anti-infectious porcine 100 μg/kg Fat the fat MRL relates agents/Antibiotics 200 μg/kg Liver to ‘skin and fat in 400 μg/kg Kidney natural proportions’.

Bovine 200 μg/kg Milk 02010R0037 — EN — 29.09.2018 — 035.001 — 23

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Clazuril NOT Pigeon No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE Clenbuterol Clenbuterol Bovine, 0,1 μg/kg Muscle NO ENTRY Agents acting on hydrochloride Equidae 0,5 μg/kg Liver the nervous system/ 0,5 μg/kg Kidney Agents acting on the autonomic Bovine 0,05 μg/kg Milk nervous system

▼M52 Clodronic acid NOT Equidae No MRL NOT Not for use in Musculoskeletal (in the form of APPLICABLE required APPLICABLE animals from which system/drugs for disodium salt) milk is produced for treatment of bone human consumption diseases ▼B Cloprostenol NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE porcine, required APPLICABLE caprine, Equidae R-Cloprostenol NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE porcine, required APPLICABLE caprine, Equidae ▼M41 Clorsulon Clorsulon Bovine 35 μg/kg Muscle NO ENTRY Antiparasitic agents/ Agents against 100 μg/kg Liver endoparasites 200 μg/kg Kidney 16 μg/kg Milk ▼M40 Closantel Closantel Bovine 1 000 μg/kg Muscle NO ENTRY Antiparasitic agents/ 3 000 μg/kg Fat Agents against 1 000 μg/kg Liver endoparasites 3 000 μg/kg Kidney 45 μg/kg Milk Ovine 1 500 μg/kg Muscle 2 000 μg/kg Fat 1 500 μg/kg Liver 5 000 μg/kg Kidney 45 μg/kg Milk ▼B Cloxacillin Cloxacillin All food 300 μg/kg Muscle For fin fish the Anti-infectious producing 300 μg/kg Fat muscle MRL relates agents/Antibiotics species 300 μg/kg Liver to ‘muscle and 300 μg/kg Kidney skin in natural 30 μg/kg Milk proportions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human con- sumption. Cobalt NOT All food No MRL NOT NO ENTRY NO ENTRY carbonate APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 24

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Cobalt dich­ NOT All food No MRL NOT NO ENTRY NO ENTRY loride APPLICABLE producing required APPLICABLE species

Cobalt NOT All food No MRL NOT NO ENTRY NO ENTRY gluconate APPLICABLE producing required APPLICABLE species

Cobalt oxide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Cobalt sulphate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Cobalt trioxide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Coco alkyl NOT All food No MRL NOT For use as excipient. NO ENTRY dimethyl APPLICABLE producing required APPLICABLE betaines species

Colistin Colistin All food 150 μg/kg Muscle For fin fish the Anti-infectious producing 150 μg/kg Fat muscle MRL relates agents/Antibiotics species 150 μg/kg Liver to ‘muscle and skin 200 μg/kg Kidney in natural propor­ 50 μg/kg Milk tions’. 300 μg/kg Eggs MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’.

Condurango NOT All food No MRL NOT NO ENTRY NO ENTRY cortex, stan­ APPLICABLE producing required APPLICABLE dardised extracts species and preparations thereof

Convallaria NOT All food No MRL NOT For use in homeo­ NO ENTRY majalis APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only. 02010R0037 — EN — 29.09.2018 — 035.001 — 25

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

▼M64

Copper NOT All food No MRL NOT NO ENTRY Alimentary tract carbonate APPLICABLE producing required APPLICABLE and metabolism/ species Mineral supplement

▼B

Copper chloride NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Copper NOT All food No MRL NOT NO ENTRY NO ENTRY gluconate APPLICABLE producing required APPLICABLE species

Copper hept­ NOT All food No MRL NOT NO ENTRY NO ENTRY anoate APPLICABLE producing required APPLICABLE species

Copper NOT All food No MRL NOT NO ENTRY NO ENTRY methionate APPLICABLE producing required APPLICABLE species

Copper oxide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Copper sulphate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Coriandri NOT All food No MRL NOT NO ENTRY NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE species

Corticotropin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Coumafos Coumafos Bees 100 μg/kg Honey NO ENTRY Antiparasitic agents/ Agents against ectoparasites

Crataegus NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Cupressi aethe­ NOT All food No MRL NOT For topical use only. NO ENTRY roleum APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 26

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Cyfluthrin (sum Bovine, 10 μg/kg Muscle For milk further Antiparasitic agents/ of isomers) caprine 50 μg/kg Fat provisions in Agents against 10 μg/kg Liver Council Directive ectoparasites 10 μg/kg Kidney 94/29/EC are to be 20 μg/kg Milk observed.

Cyhalothrin Bovine 500 μg/kg Fat For milk further Antiparasitic agents/ (sum of 50 μg/kg Kidney provisions in Agents against isomers) 50 μg/kg Milk Council Directive ectoparasites 94/29/EC are to be observed.

Cypermethrin Cypermethrin All ruminants 20 μg/kg Muscle For milk further Antiparasitic agents/ (sum of 200 μg/kg Fat provisions in Agents against isomers) 20 μg/kg Liver Commission Di- ectoparasites 20 μg/kg Kidney rective 98/82/EC are 20 μg/kg Milk to be observed.

Salmonidae 50 μg/kg Muscle and skin in natural proportions.

Cyromazine Ovine 300 μg/kg Muscle Not for use in Antiparasitic agents/ 300 μg/kg Fat animals from which Agents against 300 μg/kg Liver milk is produced for ectoparasites 300 μg/kg Kidney human consump- tion.

Cysteine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Cytidine and its NOT All food No MRL NOT NO ENTRY NO ENTRY 5’-mono-, 5’-di- APPLICABLE producing required APPLICABLE and 5’-triphos­ species phates

Danofloxacin Danofloxacin Bovine, 200 μg/kg Muscle For fin fish the Anti-infectious ovine, 100 μg/kg Fat muscle MRL relates agents/Antibiotics caprine, 400 μg/kg Liver to ‘muscle and poultry 400 μg/kg Kidney skin in natural proportions’. MRLs for fat, liver All other food 100 μg/kg Muscle and kidney do not producing 50 μg/kg Fat apply to fin fish. species 200 μg/kg Liver For porcine species 200 μg/kg Kidney the fat MRL relates to ‘skin and fat in natural proportions’. Bovine, 30 μg/kg Milk For poultry species ovine, caprine the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human con- sumption. 02010R0037 — EN — 29.09.2018 — 035.001 — 27

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Decoquinate NOT Bovine, ovine No MRL NOT For oral use only. NO ENTRY APPLICABLE required APPLICABLE Not for use in animals from which milk is produced for human consumption

Deltamethrin All ruminants 10 μg/kg Muscle NO ENTRY Antiparasitic agents/ 50 μg/kg Fat Agents against 10 μg/kg Liver ectoparasites 10 μg/kg Kidney 20 μg/kg Milk

Fin fish 10 μg/kg Muscle and skin in natural proportions.

Dembrexine NOT Equidae No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

Denaverine NOT Bovine No MRL NOT NO ENTRY NO ENTRY hydrochloride APPLICABLE required APPLICABLE

▼M4 Derquantel Derquantel Ovine 2 μg/kg Muscle Not for use in Antiparasitic agents/ 40 μg/kg Fat animals from which Agents against 20 μg/kg Liver milk is produced for endoparasites 5 μg/kg Kidney human consump- tion. ▼B NOT Equidae No MRL NOT NO ENTRY NO ENTRY acetate APPLICABLE required APPLICABLE

Detomidine NOT Bovine, No MRL NOT For therapeutic use NO ENTRY APPLICABLE Equidae required APPLICABLE only.

Dexamethasone Dexamethasone Bovine, 0,75 μg/kg Muscle NO ENTRY Corticoides/Gluco­ caprine, 2 μg/kg Liver corticoides porcine, 0,75 μg/kg Kidney Equidae

Bovine, 0,3 μg/kg Milk caprine

Dexpanthenol NOT All food-pro­ No MRL NOT NO ENTRY NO ENTRY APPLICABLE ducing required APPLICABLE species

Diazinon Bovine, 20 μg/kg Muscle For porcine species Antiparasitic agents/ ovine, 700 μg/kg Fat the fat MRL relates Agents against caprine, 20 μg/kg Liver to ‘skin and fat in ectoparasites porcine 20 μg/kg Kidney natural proportions’.

Bovine, 20 μg/kg Milk ovine, caprine 02010R0037 — EN — 29.09.2018 — 035.001 — 28

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

▼M31

Diclazuril NOT All ruminants, No MRL NOT For oral use only NO ENTRY APPLICABLE porcine required APPLICABLE

Diclazuril Poultry 500 μg/kg Muscle Not for use in Antiparasitic agents/ animals from which Agents acting 500 μg/kg Skin and fat in eggs are produced againsts protozoa natural for human proportions consumption

1 500 μg/kg Liver

1 000 μg/kg Kidney

Rabbit 150 μg/kg Muscle

300 μg/kg Fat

2 500 μg/kg Liver

1 000 μg/kg Kidney

▼B

Diclofenac Diclofenac Bovine 5 μg/kg Muscle For porcine species Anti-inflammatory 1 μg/kg Fat the fat MRL relates agents/Nonsteroidal 5 μg/kg Liver to ‘skin and fat in anti-inflammatory 10 μg/kg Kidney natural proportions’. agents 0,1 μg/kg Milk

Porcine 5 μg/kg Muscle 1 μg/kg Skin and fat 5 μg/kg Liver 10 μg/kg Kidney

Dicloxacillin Dicloxacillin All food 300 μg/kg Muscle For fin fish the Anti-infectious producing 300 μg/kg Fat muscle MRL relates agents/Antibiotics species 300 μg/kg Liver to ‘muscle and 300 μg/kg Kidney skin in natural 30 μg/kg Milk proportions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human con- sumption.

Dicopper oxide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Dicyclanil Sum of dicy­ Ovine 200 μg/kg Muscle Not for use in Antiparasitic agents/ clanil and 2, 4, 150 μg/kg Fat animals from which Agents against 6-triamino-pyri­ 400 μg/kg Liver milk is produced for ectoparasites midine-5- 400 μg/kg Kidney human consump- carbonitrile tion.

Diethyl NOT All food No MRL NOT NO ENTRY NO ENTRY phthalate APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 29

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Diethyl sebacate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M58

Diethylene NOT All food No MRL NOT NO ENTRY NO ENTRY glycol monethyl APPLICABLE producing required APPLICABLE ether species

▼B

Difloxacin Difloxacin Bovine, 400 μg/kg Muscle For fin fish the Anti-infectious ovine, caprine 100 μg/kg Fat muscle MRL relates agents/Antibiotics 1 400 μg/kg Liver to ‘muscle and skin 800 μg/kg Kidney in natural pro- portions’. Porcine 400 μg/kg Muscle MRLs for fat, liver 100 μg/kg Skin and fat and kidney do not 800 μg/kg Liver apply to fin fish. 800 μg/kg Kidney Not for use in animals from which Poultry 300 μg/kg Muscle milk is produced for 400 μg/kg Skin and fat human consump- tion. 1 900 μg/kg Liver Not for use in 600 μg/kg Kidney animals from which eggs are produced All other food 300 μg/kg Muscle for human con- producing 100 μg/kg Fat sumption. species 800 μg/kg Liver 600 μg/kg Kidney

Diflubenzuron Salmonidae 1 000 μg/kg Muscle and NO ENTRY Antiparasitic agents/ skin in natural Agents against proportions ectoparasites

Dihydrostrep­ Dihydrostrep­ All ruminants, 500 μg/kg Muscle For porcine species Anti-infectious tomycin tomycin porcine, rabbit 500 μg/kg Fat the fat MRL relates agents/Antibiotics 500 μg/kg Liver to ‘skin and fat in 1 000 μg/kg Kidney natural proportions’.

All ruminants 200 μg/kg Milk

3,5-Diiodo-L- NOT All No MRL NOT NO ENTRY NO ENTRY thyrosine APPLICABLE mammalian required APPLICABLE food producing species

Dimanganese NOT All food No MRL NOT For oral use only. NO ENTRY trioxide APPLICABLE producing required APPLICABLE species

Dimethicone NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Dimethyl NOT All food No MRL NOT NO ENTRY NO ENTRY acetamide APPLICABLE producing required APPLICABLE species

Dimethyl NOT All food No MRL NOT NO ENTRY NO ENTRY phthalate APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 30

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Dimethyl NOT All food No MRL NOT NO ENTRY NO ENTRY sulphoxide APPLICABLE producing required APPLICABLE species

Dinoprost NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Dinoprost NOT All No MRL NOT NO ENTRY NO ENTRY tromethamine APPLICABLE mammalian required APPLICABLE food producing species

Dinoprostone NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Diprophylline NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Doramectin Doramectin All 40 μg/kg Muscle For porcine species Antiparasitic agents/ mammalian 150 μg/kg Fat the fat MRL relates Agents acting food 100 μg/kg Liver to ‘skin and fat in against endo- and producing 60 μg/kg Kidney natural proportions’. ectoparasites species Not for use in animals from which milk is produced for human consump- tion.

▼M28 Double stranded NOT Bees No MRL Honey NO ENTRY NO ENTRY ribonucleic acid APPLICABLE required homologous to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel Acute Paralysis Virus

▼B Doxapram NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

▼M48

Doxycycline Doxycycline All food 100 μg/kg Muscle For fin fish the Anti-infectious producing 300 μg/kg Fat muscle MRL relates agents/Antibiotics species 300 μg/kg Liver to ‘muscle and skin 600 μg/kg Kidney in natural propor­ tions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and 02010R0037 — EN — 29.09.2018 — 035.001 — 31

▼M48

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which milk or eggs are produced for human consumption.

▼B

D-Phenylalanine NOT All food No MRL NOT NO ENTRY NO ENTRY (6) –luteinising- APPLICABLE producing required APPLICABLE hormone species releasing hormone

Echinacea NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only. For topical use only. For use in homeo­ pathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only.

Echinacea NOT All food No MRL NOT For topical use only. NO ENTRY purpurea APPLICABLE producing required APPLICABLE species

Emamectin Emamectin B1a Fin fish 100 μg/kg Muscle and NO ENTRY Antiparasitic agents/ skin in natural Agents acting proportions against endo- and ectoparasites

Enilconazole NOT Bovine, No MRL NOT For topical use only. NO ENTRY APPLICABLE Equidae required APPLICABLE

Enrofloxacin Sum of enro­ Bovine, 100 μg/kg Muscle For fin fish the Anti-infectious floxacin and ovine, caprine 100 μg/kg Fat muscle MRL relates agents/Antibiotics ciprofloxacin 300 μg/kg Liver to ‘muscle and skin 200 μg/kg Kidney in natural propor­ 100 μg/kg Milk tions’. MRLs for fat, liver Porcine, 100 μg/kg Muscle and kidney do not rabbit 100 μg/kg Fat apply to fin fish. 200 μg/kg Liver For porcine species 300 μg/kg Kidney the fat MRL relates to ‘skin and fat in Poultry 100 μg/kg Muscle natural proportions’. Not for use in 100 μg/kg Skin and fat animals from which 02010R0037 — EN — 29.09.2018 — 035.001 — 32

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

200 μg/kg Liver eggs are produced 300 μg/kg Kidney for human consumption. All other food 100 μg/kg Muscle producing 100 μg/kg Fat species 200 μg/kg Liver 200 μg/kg Kidney

Epinephrine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M76 Eprinomectin Eprinomectin All ruminants, 50 μg/kg Muscle NO ENTRY Antiparasitic agents/ B1a equidae 250 μg/kg Fat Agents acting 1 500 μg/kg Liver against endo- and 300 μg/kg Kidney ectoparasites 20 μg/kg Milk

Fin fish 50 μg/kg Muscle and skin in natural proportions

Rabbits 50 μg/kg Muscle 250 μg/kg Fat 1 500 μg/kg Liver 300 μg/kg Kidney

▼B Ergometrine NOT All No MRL NOT For use in parturient NO ENTRY maleate APPLICABLE mammalian required APPLICABLE animals only. food producing species Erythromycin Erythromycin A All food 200 μg/kg Muscle For fin fish the Anti-infectious producing 200 μg/kg Fat muscle MRL relates agents/Antibiotics species 200 μg/kg Liver to ‘muscle and skin 200 μg/kg Kidney in natural propor­ 40 μg/kg Milk tions’. 150 μg/kg Eggs MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Etamiphylline NOT All food No MRL NOT NO ENTRY NO ENTRY camsylate APPLICABLE producing required APPLICABLE species Etamsylate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species Ethanol NOT All food No MRL NOT For use as excipient. NO ENTRY APPLICABLE producing required APPLICABLE species Ethyl lactate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species Ethyl oleate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 33

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Ethylenedia­ NOT All food No MRL NOT NO ENTRY NO ENTRY minetetraacetic APPLICABLE producing required APPLICABLE acid and salts species

Etiproston NOT Bovine, No MRL NOT NO ENTRY NO ENTRY tromethamine APPLICABLE porcine required APPLICABLE

Eucalypti aethe­ NOT All food No MRL NOT NO ENTRY NO ENTRY roleum APPLICABLE producing required APPLICABLE species

Eucalyptol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Eucalyptus NOT All food No MRL NOT For use in homeo­ NO ENTRY globulus APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Euphrasia NOT All food No MRL NOT For use in homeo­ NO ENTRY officinalis APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Febantel Sum of All ruminants, 50 μg/kg Muscle For porcine species Antiparasitic agents/ extractable porcine, 50 μg/kg Fat the fat MRL relates Agents against residues which Equidae 500 μg/kg Liver to ‘skin and fat in endoparasites may be oxidised 50 μg/kg Kidney natural proportions’. to oxfendazole sulphone All ruminants 10 μg/kg Milk

▼M20

Fenbendazole Sum of All food-pro­ 50 μg/kg Muscle For porcine and Antiparasitic agents/ extractable ducing 50 μg/kg Fat poultry species the Agents against residues which species except 500 μg/kg Liver fat MRL relates to endoparasites may be oxidised fin fish 50 μg/kg Kidney ‘skin and fat in to oxfendazole 10 μg/kg Milk natural proportions’ sulfone 1 300 μg/kg Eggs

▼B

Fenpipramide NOT Equidae No MRL NOT For intravenous use NO ENTRY hydrochloride APPLICABLE required APPLICABLE only.

Fenvalerate Bovine 25 μg/kg Muscle NO ENTRY Antiparasitic agents/ (sum of RR, SS, 250 μg/kg Fat Agents against RS and SR 25 μg/kg Liver ectoparasites isomers) 25 μg/kg Kidney 40 μg/kg Milk 02010R0037 — EN — 29.09.2018 — 035.001 — 34

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Fertirelin acetate NOT Bovine No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

Firocoxib Firocoxib Equidae 10 μg/kg Muscle NO ENTRY Anti-inflammatory 15 μg/kg Fat agents/Nonsteroidal 60 μg/kg Liver anti-inflammatory 10 μg/kg Kidney agents

Florfenicol Sum of flor­ Bovine, 200 μg/kg Muscle Not for animals Anti-infectious fenicol and its ovine, caprine 3 000 μg/kg Liver from which milk is agents/Antibiotics metabolites 300 μg/kg Kidney produced for human measured as consumption. florfeni­ Porcine 300 μg/kg Muscle Not for animals col-amine 500 μg/kg Skin and fat from which eggs are 2 000 μg/kg Liver produced for human 500 μg/kg Kidney consumption. Poultry 100 μg/kg Muscle 200 μg/kg Skin and fat 2 500 μg/kg Liver 750 μg/kg Kidney

Fin fish 1 000 μg/kg Muscle and skin in natural proportions.

All other food 100 μg/kg Muscle producing 200 μg/kg Fat species 2 000 μg/kg Liver 300 μg/kg Kidney ▼M74 Fluazuron Fluazuron All ruminants 200 μg/kg Muscle Not for use in Antiparasitic agents/ except bovine animals from which Agents (acting) and ovine 7 000 μg/kg Fat milk is produced for against ecto­ human consumption parasites 500 μg/kg Liver 500 μg/kg Kidney

Bovine 200 μg/kg Muscle NO ENTRY 7 000 μg/kg Fat 500 μg/kg Liver 500 μg/kg Kidney 200 μg/kg Milk

Fin fish 200 μg/kg Muscle and NO ENTRY skin in natural proportions

▼B Flubendazole Sum of fluben­ Poultry, 50 μg/kg Muscle NO ENTRY Antiparasitic agents/ dazole and porcine 50 μg/kg Skin and fat Agents against (2-amino 1H- 400 μg/kg Liver endoparasites benzimidazol-5- 300 μg/kg Kidney yl) (4fluor­ ophenyl) methanone

Flubendazole Poultry 400 μg/kg Eggs

Flugestone Flugestone Ovine, 0,5 μg/kg Muscle For intravaginal use Agents acting on acetate acetate caprine 0,5 μg/kg Fat for zootechnical the reproductive 0,5 μg/kg Liver purposes only. system 0,5 μg/kg Kidney 1 μg/kg Milk 02010R0037 — EN — 29.09.2018 — 035.001 — 35

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Flumequine Flumequine Bovine, 200 μg/kg Muscle For porcine species Anti-infectious ovine, 300 μg/kg Fat the fat MRL relates agents/Antibiotics caprine, 500 μg/kg Liver to ‘skin and fat in porcine 1 500 μg/kg Kidney natural proportions’. Not for use in Bovine, 50 μg/kg Milk animals from which ovine, caprine eggs are produced for human con- Poultry 400 μg/kg Muscle sumption. 250 μg/kg Skin and fat 800 μg/kg Liver 1 000 μg/kg Kidney

Fin Fish 600 μg/kg Muscle and skin in natural proportion.

All other food 200 μg/kg Muscle producing 250 μg/kg Fat species 500 μg/kg Liver 1 000 μg/kg Kidney

Flumethrin (sum Bovine 10 μg/kg Muscle NO ENTRY Antiparasitic agents/ of trans-Z- 150 μg/kg Fat Agents against isomers) 20 μg/kg Liver ectoparasites 10 μg/kg Kidney 30 μg/kg Milk

Ovine 10 μg/kg Muscle Not for use in 150 μg/kg Fat animals from which 20 μg/kg Liver milk is produced for 10 μg/kg Kidney human consump- tion.

NOT Bees No MRL NOT NO ENTRY APPLICABLE required APPLICABLE

Flunixin Flunixin Bovine 20 μg/kg Muscle NO ENTRY Anti-inflammatory 30 μg/kg Fat agents/Nonsteroidal 300 μg/kg Liver anti-inflammatory 100 μg/kg Kidney agents

Porcine 50 μg/kg Muscle 10 μg/kg Skin and fat 200 μg/kg Liver 30 μg/kg Kidney

Equidae 10 μg/kg Muscle 20 μg/kg Fat 100 μg/kg Liver 200 μg/kg Kidney

5-Hydroxy­ Bovine 40 μg/kg Milk flunixin

▼M70

Fluralaner Poultry 65 μg/kg Muscle NO ENTRY Antiparasitic agents/ Agents against 650 μg/kg Skin and fat in ectoparasites natural proportions

650 μg/kg Liver

420 μg/kg Kidney

1 300 μg/kg Eggs 02010R0037 — EN — 29.09.2018 — 035.001 — 36

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Foeniculi aethe­ NOT All food No MRL NOT NO ENTRY NO ENTRY roleum APPLICABLE producing required APPLICABLE species

Folic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Follicle stimu­ NOT All food No MRL NOT NO ENTRY NO ENTRY lating hormone APPLICABLE producing required APPLICABLE (natural FSH species from all species and their synthetic analogues)

Food additives NOT All food No MRL NOT Only substances NO ENTRY (substances with APPLICABLE producing required APPLICABLE approved as a valid E species additives in food­ number stuffs for human approved as consumption, with additives in the exception of foodstuffs for preservatives listed human in part C of consumption) Annex III to European Parliament and Council Directive 95/2/EC.

Formaldehyde NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Formic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Frangulae NOT All food No MRL NOT NO ENTRY NO ENTRY cortex, stan­ APPLICABLE producing required APPLICABLE dardised extracts species and preparations thereof Furosemide NOT Bovine, No MRL NOT For intravenous ad­ NO ENTRY APPLICABLE Equidae required APPLICABLE ministration only. ▼M68 Gamithromycin Gamithromycin All ruminants 50 μg/kg Muscle Not for use in Anti-infectious except bovine animals producing agents/Antibiotics 50 μg/kg Fat milk for human consumption 300 μg/kg Liver 200 μg/kg Kidney

Bovine 20 μg/kg Fat 200 μg/kg Liver 100 μg/kg Kidney

Porcine 100 μg/kg Muscle NO ENTRY 100 μg/kg Skin and fat in natural proportions 100 μg/kg Liver 300 μg/kg Kidney 02010R0037 — EN — 29.09.2018 — 035.001 — 37

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

▼M61

Gentamicin Sum of All 50 μg/kg Muscle For fin fish the Anti-infectious gentamicin C1, mammalian 50 μg/kg Fat muscle MRL relates agents/Antibiotics gentamicin C1a, food 200 μg/kg Liver to ‘muscle and skin gentamicin C2 producing 750 μg/kg Kidney in natural propor­ and gentamicin species and 100 μg/kg Milk tions’ C2a fin fish For porcine species the fat relates to ‘skin and fat in natural proportions’

▼B

Gentianae NOT All food No MRL NOT NO ENTRY NO ENTRY radix, stan­ APPLICABLE producing required APPLICABLE dardised extracts species and preparations thereof

Ginkgo biloba NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.

Ginseng NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Ginseng, stan­ NOT All food No MRL NOT NO ENTRY NO ENTRY dardised extracts APPLICABLE producing required APPLICABLE and preparations species thereof

Glutamic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Glutamine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Glutaraldehyde NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Glycerol formal NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Glycine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 38

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Gonadotrophin NOT All food No MRL NOT NO ENTRY NO ENTRY releasing APPLICABLE producing required APPLICABLE hormone species

Guaiacol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Guanosine and NOT All food No MRL NOT NO ENTRY NO ENTRY its 5’-mono-, 5’- APPLICABLE producing required APPLICABLE di- and 5’-trip­ species hosphates

Halofuginone Halofuginone Bovine 10 μg/kg Muscle Not for use in Antiparasitic agents/ 25 μg/kg Fat animals from which Agents acting 30 μg/kg Liver milk is produced for against protozoa 30 μg/kg Kidney human consumption.

Hamamelis NOT All food No MRL NOT For use in homeo­ NO ENTRY virginiana APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per ten only.

All food No MRL NOT For topical use only. producing required APPLICABLE species

Harpagophytum NOT All food No MRL NOT For use in homeo­ NO ENTRY procumbens APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Harunga NOT All food No MRL NOT For use in homeo­ NO ENTRY madagas­ APPLICABLE producing required APPLICABLE pathic veterinary cariensis species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only

Heparin and its NOT All food No MRL NOT NO ENTRY NO ENTRY salts APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 39

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Heptaminol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Hesperidin NOT Equidae No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

Hesperidin NOT Equidae No MRL NOT NO ENTRY NO ENTRY methyl chalcone APPLICABLE required APPLICABLE

▼M53

Hexaflumuron Hexaflumuron Fin fish 500 μg/kg Muscle and NO ENTRY Antiparasitic agents/ skin in natural Agents (acting) proportions against ecto­ parasites

▼B

Hexetidine NOT Equidae No MRL NOT For topical use only. NO ENTRY APPLICABLE required APPLICABLE

Hippocastani NOT All food No MRL NOT For topical use only. NO ENTRY semen APPLICABLE producing required APPLICABLE species

Histidine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Human chorion NOT All food No MRL NOT NO ENTRY NO ENTRY gonadotrophin APPLICABLE producing required APPLICABLE species

Human NOT All food No MRL NOT NO ENTRY NO ENTRY chorionic APPLICABLE producing required APPLICABLE species (natural HCG and its synthetic analogues)

Human meno­ NOT Bovine No MRL NOT NO ENTRY NO ENTRY pausal urinary APPLICABLE required APPLICABLE gonadotrophin

Humic acids NOT All food No MRL NOT For oral use only. NO ENTRY and their APPLICABLE producing required APPLICABLE sodium salts species

Hyaluronic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Hydrochloric NOT All food No MRL NOT For use as excipient. NO ENTRY acid APPLICABLE producing required APPLICABLE species

Hydrochloro­ NOT Bovine No MRL NOT NO ENTRY NO ENTRY thiazide APPLICABLE required APPLICABLE 02010R0037 — EN — 29.09.2018 — 035.001 — 40

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Hydrocortisone NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

▼M66

Hydrocortisone Sum of hydro­ All ruminants, 10 μg/kg Milk For intramammary Corticosteroids aceponate cortisone and its Equidae use only esters after alkaline hydrolysis expressed as hydrocortisone

NOT All ruminants, No MRL NOT APPLICABLE Equidae required for APPLICABLE all tissues except milk

▼B

Hydrogen NOT All food No MRL NOT NO ENTRY NO ENTRY peroxide APPLICABLE producing required APPLICABLE species

Hydroxyethylsa­ NOT All food-pro­ No MRL NOT For topical use only. NO ENTRY licylate APPLICABLE ducing required APPLICABLE species except fin fish

8-Hydroxyqui­ NOT All No MRL NOT For topical use in NO ENTRY noline APPLICABLE mammalian required APPLICABLE newborn animals food-pro­ only. ducing species

Hyperici oleum NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Hypericum NOT All food No MRL NOT For use in homeo­ NO ENTRY perforatum APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Imidocarb Imidocarb Bovine 300 μg/kg Muscle NO ENTRY Antiparasitic agents/ 50 μg/kg Fat Agents acting 2 000 μg/kg Liver against protozoa 1 500 μg/kg Kidney 50 μg/kg Milk

Ovine 300 μg/kg Muscle Not for use in 50 μg/kg Fat animals from which 2 000 μg/kg Liver milk is produced for 1 500 μg/kg Kidney human consumption.

Inosine and its NOT All food No MRL NOT NO ENTRY NO ENTRY 5’-mono-, 5’-di- APPLICABLE producing required APPLICABLE and 5’-triphos­ species phates 02010R0037 — EN — 29.09.2018 — 035.001 — 41

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Inositol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Iodine and NOT All food No MRL NOT NO ENTRY NO ENTRY iodine inorganic APPLICABLE producing required APPLICABLE compounds species including: — Sodium and potassium- iodide — Sodium and potassium- iodate — Iodophors including polyvi­ nylpyrroli­ done-iodine

Iodine organic NOT All food No MRL NOT NO ENTRY NO ENTRY compounds APPLICABLE producing required APPLICABLE — Iodoform species

Iron ammonium NOT All food No MRL NOT NO ENTRY NO ENTRY citrate APPLICABLE producing required APPLICABLE species

Iron dextran NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Iron dichloride NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Iron fumarate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Iron glucohep­ NOT All food No MRL NOT NO ENTRY NO ENTRY tonate APPLICABLE producing required APPLICABLE species

Iron sulphate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Isobutane NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species ▼M7 Isoeugenol Isoeugenol Fin fish 6 000 μg/kg Muscle and NOT Agents acting on skin in natural APPLICABLE the nervous system/ proportions Agents acting on the central nervous system 02010R0037 — EN — 29.09.2018 — 035.001 — 42

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

▼M77

Isoflurane NOT Equidae No MRL NOT For use by inha­ General anaes­ APPLICABLE required APPLICABLE lation thetics

Porcine No MRL NOT For use by inha­ required APPLICABLE lation in piglets up to 7 days of age

▼B

Isoleucine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Isopropanol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Isoxsuprine NOT Bovine, No MRL NOT For therapeutic use NO ENTRY APPLICABLE Equidae required APPLICABLE only in accordance with Council Directive 96/22/ EEC.

▼M36

Ivermectin 22, 23-Dihydro- All 30 μg/kg Muscle For porcine species Antiparasitic agents/ avermectin B 1a mammalian 100 μg/kg Fat the fat MRL relates Agents acting food 100 μg/kg Liver to ‘skin and fat in against endo and producing 30 μg/kg Kidney natural proportions’ ectoparasites species Not for use in animals from which milk is produced for human consumption

▼B

Jecoris oleum NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Juniperi fructus NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Kanamycin Kanamycin A All food 100 μg/kg Muscle For porcine and Anti-infectious producing 100 μg/kg Fat poultry species the agents/Antibiotics species except 600 μg/kg Liver fat MRL relates to fin fish 2 500 μg/kg Kidney ‘skin and fat in 150 μg/kg Milk natural proportions’. Not for use in animals from which eggs are produced for human consumption.

Ketamine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Ketanserin NOT Equidae No MRL NOT NO ENTRY NO ENTRY tartrate APPLICABLE required APPLICABLE

Ketoprofen NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE porcine, required APPLICABLE Equidae 02010R0037 — EN — 29.09.2018 — 035.001 — 43

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Lachnanthes NOT All food No MRL NOT For use in homeo­ NO ENTRY tinctoria APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.

Lactic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Lanolin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M43

Lasalocid Lasalocid A Poultry 60 μg/kg Muscle NO ENTRY Anti-infectious 300 μg/kg Liver agents/Antibiotics 150 μg/kg Kidney 300 μg/kg Skin and fat in natural proportions 150 μg/kg Eggs

Bovine 10 μg/kg Muscle Not for use in 20 μg/kg Fat animals from which 100 μg/kg Liver milk is produced for 20 μg/kg Kidney human consumption

▼B Lauri folii NOT All food No MRL NOT NO ENTRY NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE species

Lauri fructus NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Lavandulae NOT All food No MRL NOT For topical use only. NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE species

Lecirelin NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE Equidae, required APPLICABLE rabbit

Lectin extracted NOT Porcine No MRL NOT For oral use only. NO ENTRY from red kidney APPLICABLE required APPLICABLE beans Phaseolus vulgaris

Lespedeza NOT All food No MRL NOT NO ENTRY NO ENTRY capitata APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 44

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Leucine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Levamisole Levamisole Bovine, 10 μg/kg Muscle For porcine and Antiparasitic agents/ ovine, 10 μg/kg Fat poultry species the Agents against porcine, 100 μg/kg Liver fat MRL relates to endoparasites poultry 10 μg/kg Kidney ‘skin and fat in natural proportions’. Not for use in animals from which milk or eggs are produced for human consumption.

Levomethadone NOT Equidae No MRL NOT For intravenous use NO ENTRY APPLICABLE required APPLICABLE only.

Levothyroxine NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Lidocaine NOT Equidae No MRL NOT For local-regional NO ENTRY APPLICABLE required APPLICABLE anaesthesia only.

Lincomycin Lincomycin All food-pro­ 100 μg/kg Muscle For fin fish the Anti-infectious ducing 50 μg/kg Fat muscle MRL relates agents/Antibiotics species 500 μg/kg Liver to ‘muscle and skin 1 500 μg/kg Kidney in natural propor­ 150 μg/kg Milk tions’. 50 μg/kg Eggs MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’.

Linear alkyl NOT Bovine, ovine No MRL NOT For topical use only. NO ENTRY benzene APPLICABLE required APPLICABLE sulphonic acids with alkyl chain lengths ranging from C 9 to C 13 , containing less than 2,5 % of chains longer than C 13

Lini oleum NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Lobaria NOT All food No MRL NOT For use in homeo­ NO ENTRY pulmonaria APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according 02010R0037 — EN — 29.09.2018 — 035.001 — 45

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Lobeline NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M42

Lufenuron Fin fish 1 350 μg/kg Muscle and NO ENTRY Antiparasitic agents/ (RS-isomers) (RS-isomers) skin in natural Agents (acting) proportions against ecto­ parasites

▼B

Luprostiol NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Luteinising NOT All food No MRL NOT NO ENTRY NO ENTRY hormone APPLICABLE producing required APPLICABLE (natural LH species from all species and their synthetic analogues)

Lysine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY acetate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY aluminium APPLICABLE producing required APPLICABLE silicate species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY aspartate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY carbonate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY chloride APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 46

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY citrate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY gluconate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY glutamate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY glycerop­ APPLICABLE producing required APPLICABLE hosphate species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY hydroxide APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY hypophosphite APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY orotate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY oxide APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY phosphate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY stearate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY sulphate APPLICABLE producing required APPLICABLE species

Magnesium NOT All food No MRL NOT NO ENTRY NO ENTRY trisilicate APPLICABLE producing required APPLICABLE species

Majoranae NOT All food No MRL NOT NO ENTRY NO ENTRY herba APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 47

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Malic acid NOT All food No MRL NOT For use as excipient. NO ENTRY APPLICABLE producing required APPLICABLE species

▼M30

Manganese NOT All food NO MRL NOT NO ENTRY Alimentary tract carbonate APPLICABLE producing REQUIRED APPLICABLE and metabolism/ species mineral supplements

▼B

Manganese NOT All food No MRL NOT For oral use only. NO ENTRY chloride APPLICABLE producing required APPLICABLE species

Manganese NOT All food No MRL NOT For oral use only. NO ENTRY gluconate APPLICABLE producing required APPLICABLE species

Manganese NOT All food No MRL NOT For oral use only. NO ENTRY glycerop­ APPLICABLE producing required APPLICABLE hosphate species

Manganese NOT All food No MRL NOT For oral use only. NO ENTRY oxide APPLICABLE producing required APPLICABLE species

Manganese NOT All food No MRL NOT For oral use only. NO ENTRY pidolate APPLICABLE producing required APPLICABLE species

Manganese NOT All food No MRL NOT For oral use only. NO ENTRY ribonucleate APPLICABLE producing required APPLICABLE species

Manganese NOT All food No MRL NOT For oral use only. NO ENTRY sulphate APPLICABLE producing required APPLICABLE species

Mannitol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Marbofloxacin Marbofloxacin Bovine, 150 μg/kg Muscle For porcine species Anti-infectious porcine 50 μg/kg Fat the fat MRL relates agents/Antibiotics 150 μg/kg Liver to ‘skin and fat in 150 μg/kg Kidney natural proportions’.

Bovine 75 μg/kg Milk

Matricaria NOT All food No MRL NOT NO ENTRY NO ENTRY recutita and APPLICABLE producing required APPLICABLE preparations species thereof 02010R0037 — EN — 29.09.2018 — 035.001 — 48

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Matricariae flos NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Mebendazole Sum of meben­ Ovine, 60 μg/kg Muscle Not for use in Antiparasitic agents/ dazole methyl caprine, 60 μg/kg Fat animals from which Agents against (5-(1-hydroxy, Equidae 400 μg/kg Liver milk is produced for endoparasites 1-phenyl) 60 μg/kg Kidney human con- methyl-1H- sumption. benzimidazol-2- yl) and (2-amino- 1H-benzi­ midazol-5-yl) phenylme­ thanone, expressed as mebendazole equivalents

Mecillinam NOT Bovine No MRL NOT For intrauterine use NO ENTRY APPLICABLE required APPLICABLE only.

Medicago sativa NOT All food No MRL NOT For topical use only. NO ENTRY extractum APPLICABLE producing required APPLICABLE species

Medroxyproges­ NOT Ovine No MRL NOT For intravaginal use NO ENTRY terone acetate APPLICABLE required APPLICABLE for zootechnical purposes only.

Melatonin NOT Ovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE caprine required APPLICABLE

Melissae aethe­ NOT All food No MRL NOT NO ENTRY NO ENTRY roleum APPLICABLE producing required APPLICABLE species

Melissae folium NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Meloxicam Meloxicam Bovine, 20 μg/kg Muscle NO ENTRY Anti-inflammatory caprine, 65 μg/kg Liver agents/Nonsteroidal porcine, 65 μg/kg Kidney anti-inflammatory rabbit, agents Equidae

Bovine, 15 μg/kg Milk caprine

Menadione NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 49

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Menbutone NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE ovine, required APPLICABLE caprine, porcine, Equidae

Menthae NOT All food No MRL NOT NO ENTRY NO ENTRY arvensis aethe­ APPLICABLE producing required APPLICABLE roleum species

Menthae NOT All food No MRL NOT NO ENTRY NO ENTRY piperitae aethe­ APPLICABLE producing required APPLICABLE roleum species

Menthol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Mepivacaine NOT Equidae No MRL NOT For intra-articular NO ENTRY APPLICABLE required APPLICABLE and epidural use as local anaesthetic only.

Mercaptamine NOT All No MRL NOT NO ENTRY NO ENTRY hydrochloride APPLICABLE mammalian required APPLICABLE food producing species

Metamizole 4-Methylami­ Bovine, 100 μg/kg Muscle For porcine species Anti-inflammatory noantipyrin porcine, 100 μg/kg Fat the fat MRL relates agents/Nonsteroidal Equidae 100 μg/kg Liver to ‘skin and fat in anti-inflammatory 100 μg/kg Kidney natural proportions’. agents

Bovine 50 μg/kg Milk

Methionine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Methyl NOT Bovine, No MRL NOT For topical use only. NO ENTRY nicotinate APPLICABLE Equidae required APPLICABLE

Methyl NOT All food No MRL NOT For topical use only. NO ENTRY salicylate APPLICABLE producing required APPLICABLE species except fin fish 02010R0037 — EN — 29.09.2018 — 035.001 — 50

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Methylbenzoate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M46

Methylpredni­ Methylpredni­ Equidae 10 μg/kg Muscle NO ENTRY Corticoides/Gluco­ solone solone 10 μg/kg Fat corticoides 10 μg/kg Liver 10 μg/kg Kidney 2 μg/kg Milk

Bovine 10 μg/kg Muscle NO ENTRY 10 μg/kg Fat 10 μg/kg Liver 10 μg/kg Kidney 2 μg/kg Milk

▼B 1-Methyl-2- NOT All food No MRL NOT NO ENTRY NO ENTRY pyrrolidone APPLICABLE producing required APPLICABLE species

Millefolii herba NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Mineral hydro­ NOT All food No MRL NOT Excludes aromatic NO ENTRY carbons, low to APPLICABLE producing required APPLICABLE and unsaturated high viscosity species compounds. including micor­ cristalline waxes, approxi­ mately C10- C60, aliphatic, branched aliphatic and alicyclic compounds

▼M23

Monensin Monensin A Bovine 2 μg/kg Muscle NO ENTRY Anti-infectious agents/Antibiotics 10 μg/kg Fat

50 μg/kg Liver

10 μg/kg Kidney

2 μg/kg Milk

▼M67

Monepantel Monepantel Ovine, 700 μg/kg Muscle NO ENTRY Antiparasitic agents/ sulfone caprine Agents (acting) 7 000 μg/kg Fat against endo­ parasites 5 000 μg/kg Liver

2 000 μg/kg Kidney

170 μg/kg Milk

Bovine 300 μg/kg Muscle Not for use in animals producing 7 000 μg/kg Fat milk for human consumption 2 000 μg/kg Liver

1 000 μg/kg Kidney 02010R0037 — EN — 29.09.2018 — 035.001 — 51

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009) Monothiog­ NOT All food No MRL NOT NO ENTRY NO ENTRY lycerol APPLICABLE producing required APPLICABLE species

Montanide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Morantel Sum of residues All ruminants 100 μg/kg Muscle NO ENTRY Antiparasitic agents/ which may be 100 μg/kg Fat Agents against hydrolysed to 800 μg/kg Liver endoparasites N-methyl-1,3- 200 μg/kg Kidney propanediamine 50 μg/kg Milk and expressed as morantel equivalents

Moxidectin Moxidectin Bovine, 50 μg/kg Muscle NO ENTRY Antiparasitic agents/ ovine, 500 μg/kg Fat Agents acting Equidae 100 μg/kg Liver against endo- and 50 μg/kg Kidney ectoparasites

Bovine, ovine 40 μg/kg Milk

Myglyol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Myristicae NOT All food No MRL NOT For use in newborn NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE animals only. species

Nafcillin Nafcillin All ruminants 300 μg/kg Muscle For intramammary Anti-infectious 300 μg/kg Fat use only. agents/Antibiotics 300 μg/kg Liver 300 μg/kg Kidney 30 μg/kg Milk

Natamycin NOT Bovine, No MRL NOT For topical use only. NO ENTRY APPLICABLE Equidae required APPLICABLE

▼M29

Neomycin Neomycin B All food 500 μg/kg Muscle For fin fish the Anti-infectious (including producing muscle MRL relates agents/Antibiotics framycetin) species 500 μg/kg Fat to ‘muscle and skin in natural propor­ tions’. 5 500 μg/kg Liver MRLs for fat, liver and kidney do not 9 000 μg/kg Kidney apply to fin fish. For porcine and 1 500 μg/kg Milk poultry species the fat MRL relates to 500 μg/kg Eggs ‘skin and fat in natural proportions’

▼B

Neostigmine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 52

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Netobimin Sum of alben­ Bovine, ovine 100 μg/kg Muscle For oral use only. Antiparasitic agents/ dazole oxide, 100 μg/kg Fat Agents against albendazole 1 000 μg/kg Liver endoparasites sulphone, and 500 μg/kg Kidney albendazole 2- 100 μg/kg Milk amino sulphone, expressed as albendazole

Nickel NOT All food No MRL NOT NO ENTRY NO ENTRY gluconate APPLICABLE producing required APPLICABLE species

Nickel sulphate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Nicoboxil NOT Equidae No MRL NOT For topical use only. NO ENTRY APPLICABLE required APPLICABLE

▼M14

Nitroxinil Nitroxinil Bovine, ovine 400 μg/kg Muscle Antiparasitic agents/ agents against endoparasites 200 μg/kg Fat

20 μg/kg Liver

400 μg/kg Kidney

20 μg/kg Milk

▼B

Nonivamide NOT Equidae No MRL NOT For topical use only NO ENTRY APPLICABLE required APPLICABLE

Norgestomet Norgestomet Bovine 0,2 μg/kg Muscle For therapeutic and Agents acting on 0,2 μg/kg Fat zootechnical the reproductive 0,2 μg/kg Liver purposes only. system 0,2 μg/kg Kidney 0,12 μg/kg Milk

Novobiocin Novobiocin Bovine 50 μg/kg Milk For intramammary Anti-infectious use only. agents/Antibiotics

NOT Bovine No MRL NOT NO ENTRY APPLICABLE required for APPLICABLE all tissues except milk 02010R0037 — EN — 29.09.2018 — 035.001 — 53

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

▼M11 Octenidine NOT All mamma- No MRL NOT For cutaneous use Anti-infectious dihydrochloride APPLICABLE lian food-pro­ required APPLICABLE only. agents/Antiseptics ducing species

▼B 17β-Oestradiol NOT All mamma- No MRL NOT For therapeutic and NO ENTRY APPLICABLE lian food required APPLICABLE zootechnical use producing only. species

Okoubaka NOT All food No MRL NOT For use in homeo­ NO ENTRY aubrevillei APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Oleyloleate NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Omeprazole NOT Equidae No MRL NOT For oral use only. NO ENTRY APPLICABLE required APPLICABLE

Orgotein NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Ornithine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Orotic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Oxacillin Oxacillin All food 300 μg/kg Muscle For fin fish the Anti-infectious producing 300 μg/kg Fat muscle MRL relates agents/Antibiotics species 300 μg/kg Liver to ‘muscle and 300 μg/kg Kidney skin in natural 30 μg/kg Milk proportions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human con- sumption. 02010R0037 — EN — 29.09.2018 — 035.001 — 54

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Oxalic acid NOT Bees No MRL NOT NO ENTRY Anti-infectious APPLICABLE required APPLICABLE agent

Oxfendazole Sum of All ruminants, 50 μg/kg Muscle For porcine species Antiparasitic agents/ extractable porcine, 50 μg/kg Fat the fat MRL relates Agents against residues which Equidae 500 μg/kg Liver to ‘skin and fat in endoparasites may be oxidised 50 μg/kg Kidney natural proportions’. to oxfendazole sulphone

All ruminants 10 μg/kg Milk

Oxibendazole Oxibendazole Porcine 100 μg/kg Muscle NO ENTRY Antiparasitic agents/ 500 μg/kg Skin and fat Agents against 200 μg/kg Liver endoparasites 100 μg/kg Kidney

Oxidation NOT Bovine, No MRL NOT NO ENTRY NO ENTRY products of APPLICABLE ovine, required APPLICABLE Terebinthinae caprine, oleum porcine

Oxolinic acid Oxolinic acid All food 100 μg/kg Muscle For fin fish the Anti-infectious producing 50 μg/kg Fat muscle MRL relates agents/Antibiotics species 150 μg/kg Liver to ‘muscle and skin 150 μg/kg Kidney in natural pro- portions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which milk or eggs are produced for human consump- tion.

Oxyclozanide Oxyclozanide All ruminants 20 μg/kg Muscle NO ENTRY Antiparasitic agents/ 20 μg/kg Fat Agents against 500 μg/kg Liver endoparasites 100 μg/kg Kidney 10 μg/kg Milk

Oxytetracycline Sum of parent All food-pro­ 100 μg/kg Muscle For fin fish the Anti-infectious drug and its 4- ducing 300 μg/kg Liver muscle MRL relates agents/Antibiotics epimer species 600 μg/kg Kidney to ‘muscle and skin 100 μg/kg Milk in natural pro- 200 μg/kg Eggs portions’. 02010R0037 — EN — 29.09.2018 — 035.001 — 55

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

►C1 MRLs for liver and kidney do not apply to fin fish. ◄

Oxytocin NOT All No MRL NOT NO ENTRY NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Pancreatin NOT All No MRL NOT For topical use only. NO ENTRY APPLICABLE mammalian required APPLICABLE food producing species

Papain NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Papaverine NOT Bovine No MRL NOT Newborn calves NO ENTRY APPLICABLE required APPLICABLE only.

Paracetamol NOT Porcine No MRL NOT For oral use only. NO ENTRY APPLICABLE required APPLICABLE

Parconazole NOT Guinea fowl No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

Paromomycin Paromomycin All food 500 μg/kg Muscle For fin fish the Anti-infectious producing 1 500 μg/kg Liver muscle MRL relates agents/Antibiotics species 1 500 μg/kg Kidney to ‘muscle and skin in natural pro- portions’. MRLs for liver and kidney do not apply to fin fish. Not for use in animals from which milk or eggs are produced for human consump- tion.

Peforelin NOT Porcine No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

▼M15

Pegylated NOT Bovine No MRL NOT NO ENTRY Biological/Immuno­ bovine granu­ APPLICABLE required APPLICABLE modulator locyte colony stimulating factor

▼B

Penethamate Benzylpenicillin All 50 μg/kg Muscle For porcine species Anti-infectious mammalian 50 μg/kg Fat the fat MRL relates agents/Antibiotics food 50 μg/kg Liver to ‘skin and fat in producing 50 μg/kg Kidney natural proportions’. species 4 μg/kg Milk 02010R0037 — EN — 29.09.2018 — 035.001 — 56

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Pepsin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Peracetic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Permethrin (sum Bovine 50 μg/kg Muscle For milk further Antiparasitic agents/ of isomers) 500 μg/kg Fat provisions in Agents against 50 μg/kg Liver Commission ectoparasites 50 μg/kg Kidney Directive 98/82/EC 50 μg/kg Milk are to be observed.

Phenol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M8 Phenoxymethyl­ Phenoxymethyl­ Porcine 25 μg/kg Muscle NO ENTRY Anti-infectious penicillin penicillin agents/Antibiotics 25 μg/kg Liver

25 μg/kg Kidney Poultry 25 μg/kg Muscle

25 μg/kg Skin and fat

25 μg/kg Liver

25 μg/kg Kidney

25 μg/kg Eggs

▼B Phenylalanine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Phloroglucinol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M21

Phoxim All food-pro­ 25 μg/kg Muscle For porcine and Antiparasitic agents/ ducing 550 μg/kg Fat poultry species the Agents against species except 50 μg/kg Liver fat MRL relates to ectoparasites. fin fish. 30 μg/kg Kidney ‘skin and fat in 60 μg/kg Eggs natural proportions’. Not for use in animals from which milk is produced for human consumption. 02010R0037 — EN — 29.09.2018 — 035.001 — 57

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Phytolacca NOT All food No MRL NOT For use in homeo­ NO ENTRY americana APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only.

Phytomenadione NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Piceae turiones NOT All food No MRL NOT For oral use only. NO ENTRY recentes APPLICABLE producing required APPLICABLE extractum species

Piperazine Piperazine Porcine 400 μg/kg Muscle NO ENTRY Antiparasitic agents/ 800 μg/kg Skin and fat Agents against 2 000 μg/kg Liver endoparasites 1 000 μg/kg Kidney

Chicken 2 000 μg/kg Eggs

Piperazine dihy­ NOT Chicken No MRL NOT NO ENTRY NO ENTRY drochloride APPLICABLE required for APPLICABLE all tissues except eggs

Piperonyl NOT Bovine, No MRL NOT For topical use only. NO ENTRY butoxide APPLICABLE ovine, required APPLICABLE caprine, Equidae

Pirlimycin Pirlimycin Bovine 100 μg/kg Muscle NO ENTRY Anti-infectious 100 μg/kg Fat agents/Antibiotics 1 000 μg/kg Liver 400 μg/kg Kidney 100 μg/kg Milk

Policresulen NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Poloxalene NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Poloxamer NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 58

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Polyethylene NOT All food No MRL NOT For use as excipient. NO ENTRY glycol 15 APPLICABLE producing required APPLICABLE hydroxystearate species

Polyethylene NOT All food No MRL NOT For topical use only. NO ENTRY glycol 7 APPLICABLE producing required APPLICABLE glyceryl cocoate species

Polyethylene NOT All food No MRL NOT For use as excipient. NO ENTRY glycol stearates APPLICABLE producing required APPLICABLE with 8-40 species oxyethylene units

Polyethylene NOT All food No MRL NOT NO ENTRY NO ENTRY glycols (mol­ APPLICABLE producing required APPLICABLE ecular weight species ranging from 200 to 10 000)

Polyoxyethylene NOT All food No MRL NOT NO ENTRY NO ENTRY sorbitan mono­ APPLICABLE producing required APPLICABLE oleate and species trioleate

Polyoxyl castor NOT All food No MRL NOT For use as excipient. NO ENTRY oil with 30 APPLICABLE producing required APPLICABLE to 40 species oxyethylene units

Polyoxyl hydro­ NOT All food No MRL NOT For use as excipient. NO ENTRY genated castor APPLICABLE producing required APPLICABLE oil with 40 species to 60 oxyethylene units

Polysorbate 80 NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Polysulphated NOT Equidae No MRL NOT NO ENTRY NO ENTRY glycosami­ APPLICABLE required APPLICABLE noglycan

▼M75

Porcine NOT Porcine No MRL NOT For oral use in Agents acting on prolactin APPLICABLE required APPLICABLE newborn piglets at a the reproductive dose of up to system 0,2 mg/animal. For use in sows at a total dose of up to 5 mg/animal.

▼B

Potassium NOT All food No MRL NOT NO ENTRY NO ENTRY DL-aspartate APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 59

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Potassium NOT All food No MRL NOT NO ENTRY NO ENTRY glucuronate APPLICABLE producing required APPLICABLE species

Potassium NOT All food No MRL NOT NO ENTRY NO ENTRY glycerop­ APPLICABLE producing required APPLICABLE hosphate species

Potassium NOT All food No MRL NOT NO ENTRY NO ENTRY nitrate APPLICABLE producing required APPLICABLE species

Potassium NOT All food No MRL NOT NO ENTRY NO ENTRY selenate APPLICABLE producing required APPLICABLE species

Praziquantel NOT Ovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE Equidae required APPLICABLE

▼M27

Prednisolone Prednisolone Bovine 4 μg/kg Muscle NO ENTRY Corticoids/Gluco­ corticoids 4 μg/kg Fat

10 μg/kg Liver

10 μg/kg Kidney

6 μg/kg Milk

Equidae 4 μg/kg Muscle

8 μg/kg Fat

6 μg/kg Liver

15 μg/kg Kidney

▼B

Pregnant mare NOT All food No MRL NOT NO ENTRY NO ENTRY serum gonadot­ APPLICABLE producing required APPLICABLE rophin species

Prethcamide NOT All No MRL NOT NO ENTRY NO ENTRY (crotethamide APPLICABLE mammalian required APPLICABLE and cropro­ food pamide) producing species

Procaine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 60

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Progesterone NOT Bovine, No MRL NOT Only for intra­ NO ENTRY APPLICABLE ovine, required APPLICABLE vaginal therapeutic caprine, or zootechnical use Equidae and in accordance (female) with the provisions of Directive 96/22/ EC.

Proline NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Propane NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M54

Propyl 4- NOT All food No MRL NOT For use as a NO ENTRY hydroxy­ APPLICABLE producing required APPLICABLE preservative only benzoate and its species sodium salt

▼B

Propylene NOT All food No MRL NOT NO ENTRY NO ENTRY glycol APPLICABLE producing required APPLICABLE species

Prunus laur­ NOT All food No MRL NOT For use in homeo­ NO ENTRY ocerasus APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.

▼M60

Purified NOT Bees No MRL Honey NO ENTRY Antiparasitic agents/ semi-solid APPLICABLE required Agents against extract from ectoparasites Humulus lupulus L. containing approximately 48 % of beta acids (as potassium salts)

▼B

Pyrantel NOT Equidae No MRL NOT NO ENTRY NO ENTRY embonate APPLICABLE required APPLICABLE

Pyrethrum NOT All food No MRL NOT For topical use only. NO ENTRY extract APPLICABLE producing required APPLICABLE species

2-Pyrrolidone NOT All food No MRL NOT At parenteral doses NO ENTRY APPLICABLE producing required APPLICABLE up to 40 mg/kg bw. species 02010R0037 — EN — 29.09.2018 — 035.001 — 61

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Quatresin NOT All food No MRL NOT For use as NO ENTRY APPLICABLE producing required APPLICABLE preservative only at species concentrations of up to 0,5 %.

Quercus cortex NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Quillaia NOT All food No MRL NOT NO ENTRY NO ENTRY saponins APPLICABLE producing required APPLICABLE species

▼M63

Rafoxanide Rafoxanide Bovine 30 μg/kg Muscle NO ENTRY Antiparasitic agents/ Agents against 30 μg/kg Fat endoparasites 10 μg/kg Liver 40 μg/kg Kidney

Ovine 100 μg/kg Muscle 250 μg/kg Fat 150 μg/kg Liver 150 μg/kg Kidney

Bovine, ovine 10 μg/kg Milk Provisional MRL shall expire on 31 December 2017

▼B

Rhei radix, NOT All food No MRL NOT NO ENTRY NO ENTRY standardised APPLICABLE producing required APPLICABLE extracts and species preparations thereof

Ricini oleum NOT All food No MRL NOT For use as excipient. NO ENTRY APPLICABLE producing required APPLICABLE species

Rifaximin Rifaximin Bovine 60 μg/kg Milk NO ENTRY Anti-infectious agents/Antibiotics NOT Bovine No MRL NOT For intramammary APPLICABLE required for APPLICABLE use, except if the all tissues udder may be used except milk as food for human consumption, and intrauterine use only.

All No MRL NOT For topical use only. mammalian required APPLICABLE food producing species

Romifidine NOT Equidae No MRL NOT For therapeutic uses NO ENTRY APPLICABLE required APPLICABLE only. 02010R0037 — EN — 29.09.2018 — 035.001 — 62

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Rosmarini NOT All food No MRL NOT NO ENTRY NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE species

Rosmarini NOT All food No MRL NOT NO ENTRY NO ENTRY folium APPLICABLE producing required APPLICABLE species

Ruscus NOT All food No MRL NOT For topical use only. NO ENTRY aculeatus APPLICABLE producing required APPLICABLE species

Ruta graveolens NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only. Not for use in animals from which milk is produced for human consump- tion.

Salicylic acid NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species except fin fish

Salviae folium NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Sambuci flos NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Sarafloxacin Sarafloxacin Chicken 10 μg/kg Skin and fat Not for use in Anti-infectious 100 μg/kg Liver animals from which agents/Antibiotics eggs are produced for human con- sumption.

Salmonidae 30 μg/kg Muscle and skin in natural proportions 02010R0037 — EN — 29.09.2018 — 035.001 — 63

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Selenicereus NOT All food No MRL NOT For use in homeo­ NO ENTRY grandiflorus APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only.

Serenoa repens NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Serine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Serotonin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Silybum NOT All food No MRL NOT For use in homeo­ NO ENTRY marianum APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Sinapis nigrae NOT All food No MRL NOT NO ENTRY NO ENTRY semen APPLICABLE producing required APPLICABLE species

▼M59

Sisapronil Sisapronil Bovine, 100 μg/kg Muscle Not for use in Antiparasitic agents/ caprine 2 000 μg/kg Fat animals from which Agents against 200 μg/kg Liver milk is produced for ectoparasites 100 μg/kg Kidney human consumption 02010R0037 — EN — 29.09.2018 — 035.001 — 64

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Sodium 2- NOT Bovine, No MRL NOT NO ENTRY NO ENTRY methyl-2- APPLICABLE porcine, required APPLICABLE phenoxy- caprine, propanoate Equidae

Sodium acetyl­ NOT All food No MRL NOT Not for use in NO ENTRY salicylate APPLICABLE producing required APPLICABLE animals from which species except milk or eggs are fin fish produced for human consumption.

Sodium benzyl NOT All food No MRL NOT NO ENTRY NO ENTRY 4-hydroxy­ APPLICABLE producing required APPLICABLE benzoate species

Sodium boro­ NOT All food No MRL NOT NO ENTRY NO ENTRY formiate APPLICABLE producing required APPLICABLE species

Sodium butyl 4- NOT All food No MRL NOT NO ENTRY NO ENTRY hydroxy­ APPLICABLE producing required APPLICABLE benzoate species

Sodium cetos­ NOT All food No MRL NOT For topical use only. NO ENTRY tearyl sulphate APPLICABLE producing required APPLICABLE species

Sodium chloride NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Sodium chlorite NOT Bovine No MRL NOT For topical use only. NO ENTRY APPLICABLE required APPLICABLE

Sodium NOT All food No MRL NOT NO ENTRY NO ENTRY cromoglycate APPLICABLE producing required APPLICABLE species

Sodium dich­ NOT Bovine, No MRL NOT For topical use only. NO ENTRY loroisocyanurate APPLICABLE ovine, caprine required APPLICABLE

Sodium dioc­ NOT All food No MRL NOT NO ENTRY NO ENTRY tylsulphosuc­ APPLICABLE producing required APPLICABLE cinate species

Sodium formal­ NOT All food No MRL NOT NO ENTRY NO ENTRY dehydesul­ APPLICABLE producing required APPLICABLE phoxylate species 02010R0037 — EN — 29.09.2018 — 035.001 — 65

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Sodium glyce­ NOT All food No MRL NOT NO ENTRY NO ENTRY rophosphate APPLICABLE producing required APPLICABLE species

Sodium hypo­ NOT All food No MRL NOT NO ENTRY NO ENTRY phosphite APPLICABLE producing required APPLICABLE species

Sodium lauryl NOT All food No MRL NOT NO ENTRY NO ENTRY sulphate APPLICABLE producing required APPLICABLE species

Sodium nitrite NOT Bovine No MRL NOT For topical use only. NO ENTRY APPLICABLE required APPLICABLE

Sodium NOT All food No MRL NOT NO ENTRY NO ENTRY propionate APPLICABLE producing required APPLICABLE species

Sodium pyro­ NOT All food No MRL NOT NO ENTRY NO ENTRY sulphite APPLICABLE producing required APPLICABLE species

▼M22

Sodium NOT Bovine, No MRL NOT For oral use. NO ENTRY salicylate APPLICABLE porcine required APPLICABLE Not for use in animals from which milk is produced for human consumption.

All food No MRL NOT For topical use only. producing required APPLICABLE species except fin fish

Salicylic acid Turkey 400 μg/kg Muscle Not for use in Anti-inflammatory 2 500 μg/kg Skin and fat in animals producing agents/Non- natural eggs for human steroidal proportions consumption. anti-inflammatory 200 μg/kg Liver agents 150 μg/kg Kidney

▼B

Sodium selenate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Sodium selenite NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 66

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Sodium stearate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Sodium thio­ NOT All food No MRL NOT NO ENTRY NO ENTRY sulphate APPLICABLE producing required APPLICABLE species

Solidago NOT All food No MRL NOT For use in homeo­ NO ENTRY virgaurea APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

▼M73

Solvent naphtha, NOT All food No MRL NOT For cutaneous use NO ENTRY light aromatic, APPLICABLE producing required APPLICABLE only. with cumene species Only at volume not concentration exceeding 15 μl not exceeding solvent naphtha/kg 2,5 %, and bw. benzene concen­ tration not exceeding 0,0002 %

▼B

Somatosalm NOT Salmon No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

Sorbitan NOT All food No MRL NOT NO ENTRY NO ENTRY sesquioleate APPLICABLE producing required APPLICABLE species

Sorbitan NOT All food-pro­ No MRL NOT NO ENTRY NO ENTRY trioleate APPLICABLE ducing required APPLICABLE species

Spectinomycin Spectinomycin Ovine 300 μg/kg Muscle For fin fish the Anti-infectious 500 μg/kg Fat muscle MRL relates agents/Antibiotics 2 000 μg/kg Liver to ‘muscle and skin 5 000 μg/kg Kidney in natural pro- 200 μg/kg Milk portions’. MRLs for fat, liver All other food 300 μg/kg Muscle and kidney do not producing 500 μg/kg Fat apply to fin fish. species 1 000 μg/kg Liver For porcine and 5 000 μg/kg Kidney poultry species the 200 μg/kg Milk fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human consumption. 02010R0037 — EN — 29.09.2018 — 035.001 — 67

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Spiramycin Sum of Bovine 200 μg/kg Muscle NO ENTRY Anti-infectious spiramycin and 300 μg/kg Fat agents/Antibiotics neospiramycin 300 μg/kg Liver 300 μg/kg Kidney 200 μg/kg Milk

Chicken 200 μg/kg Muscle Not for use in 300 μg/kg Skin and fat animals from which 400 μg/kg Liver eggs are produced for human con- sumption.

Spiramycin 1 Porcine 250 μg/kg Muscle NO ENTRY 2 000 μg/kg Liver 1 000 μg/kg Kidney

Streptomycin Streptomycin All ruminants, 500 μg/kg Muscle For porcine species Anti-infectious porcine, rabbit 500 μg/kg Fat the fat MRL relates agents/Antibiotics 500 μg/kg Liver to ‘skin and fat in 1 000 μg/kg Kidney natural proportions’.

All ruminants 200 μg/kg Milk

Strychni semen NOT Bovine, No MRL NOT For oral use only at NO ENTRY APPLICABLE ovine, caprine required APPLICABLE doses up to the equivalent of 0,1 mg / kg bw.

Strychnine NOT Bovine No MRL NOT For oral use only at NO ENTRY APPLICABLE required APPLICABLE dose to 0,1 mg/kg bw.

Substances used NOT All food No MRL NOT All substances used NO ENTRY in homeopathic APPLICABLE producing required APPLICABLE in homeopathic veterinary species veterinary medicinal medicines products provided that their concen­ tration in the product does not exceed one part per ten thousand.

Sulfogaiacol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 68

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Sulfonamides Parent drug All food-pro­ 100 μg/kg Muscle The combined total Anti-infectious (all substances ducing 100 μg/kg Fat residues of all agents/Chemotheu­ belonging to the species 100 μg/kg Liver substances within rapeutics/ sulfonamide 100 μg/kg Kidney the sulfonamide group) group should not exceed 100 μg/kg. For fin fish the muscle MRL relates Bovine, 100 μg/kg Milk to ‘muscle and skin ovine, caprine in natural propor­ tions’. MRLs for fat, liver and kidney do not apply to fin fish. Not for use in animals from which eggs are produced for human con- sumption.

Sulphur NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Symphyti radix NOT All food No MRL NOT For topical use on NO ENTRY APPLICABLE producing required APPLICABLE intact skin only. species

Syzygium cumini NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Tanninum NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

L-tartaric acid NOT All food No MRL NOT For use as excipient. NO ENTRY and its mono- APPLICABLE producing required APPLICABLE and di-basic salt species of sodium, potassium and calcium 02010R0037 — EN — 29.09.2018 — 035.001 — 69

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Tau fluvalinate NOT Bees No MRL NOT NO ENTRY NO ENTRY APPLICABLE required APPLICABLE

Teflubenzuron Teflubenzuron Salmonidae 500 μg/kg Muscle and NO ENTRY Antiparasitic agents/ skin in natural Agents against proportions ectoparasites

Terebinthinae NOT All food No MRL NOT For topical use only. NO ENTRY aetheroleum APPLICABLE producing required APPLICABLE rectificatum species

Terebinthinae NOT All food No MRL NOT For topical use only. NO ENTRY laricina APPLICABLE producing required APPLICABLE species

Terpin hydrate NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE ovine, required APPLICABLE caprine, porcine

Tetracaine NOT All food No MRL NOT For use as anaes­ NO ENTRY APPLICABLE producing required APPLICABLE thetic only. species

Tetracycline Sum of parent All food-pro­ 100 μg/kg Muscle For fin fish the Anti-infectious drug and its 4- ducing 300 μg/kg Liver muscle MRL relates agents/Antibiotics epimer species 600 μg/kg Kidney to ‘muscle and skin 100 μg/kg Milk in natural pro- 200 μg/kg Eggs portions’. MRLs for liver and kidney do not apply to fin fish.

Theobromine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Theophylline NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Thiabendazole Sum of thiaben­ Bovine, 100 μg/kg Muscle NO ENTRY Antiparasitic agents/ dazole and 5- caprine 100 μg/kg Fat Agents against hydroxythiaben­ 100 μg/kg Liver endoparasites dazole 100 μg/kg Kidney 100 μg/kg Milk 02010R0037 — EN — 29.09.2018 — 035.001 — 70

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Thiamphenicol Thiamphenicol All food 50 μg/kg Muscle For fin fish the Anti-infectious producing 50 μg/kg Fat muscle MRL relates agents/Antibiotics species 50 μg/kg Liver to ‘muscle and skin 50 μg/kg Kidney in natural pro- 50 μg/kg Milk portions’. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human con- sumption.

Thiamylal NOT All No MRL NOT For intravenous ad­ NO ENTRY APPLICABLE mammalian required APPLICABLE ministration only. food producing species

Thioctic acid NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Thiomersal NOT All food No MRL NOT For use only as NO ENTRY APPLICABLE producing required APPLICABLE preservatives in species multidose vaccines at a concentration not exceeding 0,02 %.

Thiopental NOT All food No MRL NOT For intravenous ad­ NO ENTRY sodium APPLICABLE producing required APPLICABLE ministration only. species

Threonine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Thuja occi­ NOT All food No MRL NOT For use in homeo­ NO ENTRY dentalis APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only. 02010R0037 — EN — 29.09.2018 — 035.001 — 71

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Thymi aethe­ NOT All food No MRL NOT NO ENTRY NO ENTRY roleum APPLICABLE producing required APPLICABLE species

Thymidine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Thymol NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Tiamulin Sum of meta­ Porcine, 100 μg/kg Muscle NO ENTRY Anti-infectious bolites that may rabbit 500 μg/kg Liver agents/Antibiotics be hydrolysed to 8-α-hydroxy­ mutilin Chicken 100 μg/kg Muscle 100 μg/kg Skin and fat 1 000 μg/kg Liver

Turkey 100 μg/kg Muscle 100 μg/kg Skin and fat 300 μg/kg Liver

Tiamulin Chicken 1 000 μg/kg Eggs

Tiaprost NOT Bovine, No MRL NOT NO ENTRY NO ENTRY APPLICABLE ovine, required APPLICABLE porcine, Equidae

▼M35

Tildipirosin Tildipirosin Bovine, 400 μg/kg Muscle Not for use in Anti-infectious caprine animals from which agents/Antibiotics milk is produced for 200 μg/kg Fat human consumption.

2 000 μg/kg Liver

3 000 μg/kg Kidney

Porcine 1 200 μg/kg Muscle

800 μg/kg Skin and fat in natural proportions

5 000 μg/kg Liver

10 000 μg/kg Kidney 02010R0037 — EN — 29.09.2018 — 035.001 — 72

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Tiliae flos NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Tilmicosin Tilmicosin Poultry 75 μg/kg Muscle For fin fish the Anti-infectious 75 μg/kg Skin and fat muscle MRL relates agents/Antibiotics 1 000 μg/kg Liver to a ‘muscle and 250 μg/kg Kidney skin in natural proportions’. MRLs for fat, liver and kidney do not All other food 50 μg/kg Muscle apply to fin fish. producing 50 μg/kg Fat For porcine species species 1 000 μg/kg Liver the fat MRL relates 1 000 μg/kg Kidney to ‘skin and fat in 50 μg/kg Milk natural proportions’. Not for use in animals from which eggs are produced for human con- sumption.

Tiludronic acid NOT Equidae No MRL NOT For intravenous use NO ENTRY (in the form of APPLICABLE required APPLICABLE only. disodium salt)

Poultry No MRL NOT For parenteral use required APPLICABLE only and for use in laying and breeder birds only.

Timerfonate NOT All food No MRL NOT For use only as NO ENTRY APPLICABLE producing required APPLICABLE preservatives in species multidose vaccines at a concentration not exceeding 0,02 %.

Toldimfos NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Tolfenamic acid Tolfenamic acid Bovine, 50 μg/kg Muscle NO ENTRY Anti-inflammatory porcine 400 μg/kg Liver agents/Nonsteroidal 100 μg/kg Kidney anti-inflammatory agents

Bovine 50 μg/kg Milk 02010R0037 — EN — 29.09.2018 — 035.001 — 73

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Toltrazuril Toltrazuril All 100 μg/kg Muscle For porcine species Antiparasitic agents/ sulfone mammalian 150 μg/kg Fat the fat MRL relates Agents acting food 500 μg/kg Liver to ‘skin and fat in against protozoa producing 250 μg/kg Kidney natural proportions’. species Not for use in animals from which milk is produced for human consump- tion. Poultry 100 μg/kg Muscle Not for use in 200 μg/kg Skin and fat animals from which 600 μg/kg Liver eggs are produced 400 μg/kg Kidney for human con- sumption.

Tosylchloramide NOT Bovine, No MRL NOT For topical use only. NO ENTRY sodium APPLICABLE Equidae required APPLICABLE

Fin fish No MRL NOT For water-borne use required APPLICABLE only.

Tragacanth NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Tricaine NOT Fin fish No MRL NOT For water borne use NO ENTRY mesilate APPLICABLE required APPLICABLE only.

Trichlorme­ NOT All No MRL NOT NO ENTRY NO ENTRY thiazide APPLICABLE mammalian required APPLICABLE food producing species

▼M37

Triclabendazole Sum of the All ruminants 225 μg/kg Muscle NO ENTRY Antiparasitic agents/ extractable 100 μg/kg Fat Agents against residues that 250 μg/kg Liver endoparasites may be oxidised 150 μg/kg Kidney to ketotriclaben­ 10 μg/kg Milk dazole 02010R0037 — EN — 29.09.2018 — 035.001 — 74

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Trimethoprim Trimethoprim Equidae 100 μg/kg Fat For fin fish the Anti-infectious 100 μg/kg Muscle muscle MRL relates agents/ 100 μg/kg Liver to a ‘muscle and Chemotheurapeutics 100 μg/kg Kidney skin in natural proportions’. All other food 50 μg/kg Muscle MRLs for fat, liver producing 50 μg/kg Fat and kidney do not species 50 μg/kg Liver apply to fin fish. 50 μg/kg Kidney For porcine and 50 μg/kg Milk poultry species the fat MRL relates to ‘skin and fat in natural proportions’. Not for use in animals from which eggs are produced for human con- sumption.

Trimethylphlo­ NOT All food No MRL NOT NO ENTRY NO ENTRY roglucinol APPLICABLE producing required APPLICABLE species

▼M34

Triptorelin NOT All food No MRL NOT NO ENTRY Agents acting on acetate APPLICABLE producing required APPLICABLE the reproductive species system

▼B

Trypsin NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Tryptophan NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M50

Tulathromycin (2R,3S,4R, Ovine, 450 μg/kg Muscle Not for use in Anti-infectious 5R,8R,10R, caprine animals from which agents/Antibiotics 11R,12S, 250 μg/kg Fat milk is produced for 13S,14R)-2- human consumption ethyl-3,4,10,13- 5 400 μg/kg Liver tetra-hydroxy- 3,5,8,10,12,14- 1 800 μg/kg Kidney hexamethyl-11- [[3,4,6-trideoxy- Bovine 300 μg/kg Muscle 3-(dimethy- lamino)-ß-D- 200 μg/kg Fat xylo-hexopyr­ anosyl]oxy]-1- 4 500 μg/kg Liver oxa-6- azacyclopent- 3 000 μg/kg Kidney decan-15-one expressed as Porcine 800 μg/kg Muscle tulathromycin equivalents 300 μg/kg Skin and fat in natural proportions

4 000 μg/kg Liver

8 000 μg/kg Kidney 02010R0037 — EN — 29.09.2018 — 035.001 — 75

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Turnera diffusa NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations co- rresponding to the mother tincture and dilutions thereof only.

Tylosin Tylosin A All food 100 μg/kg Muscle For fin fish the Anti-infectious producing 100 μg/kg Fat muscle MRL relates agents/Antibiotics species 100 μg/kg Liver to a ‘muscle and 100 μg/kg Kidney skin in natural 50 μg/kg Milk proportions’. 200 μg/kg Eggs MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to ‘skin and fat in natural proportions’.

▼M62

Tylvalosin Sum of Porcine 50 μg/kg Muscle NO ENTRY Anti-infectious tylvalosin and agents/Antibiotics 3-O-acetyl­ 50 μg/kg Skin and fat tylosin 50 μg/kg Liver

50 μg/kg Kidney

Poultry 50 μg/kg Skin and fat

50 μg/kg Liver

Tylvalosin Poultry 200 μg/kg Eggs

▼B

Tyrosine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Urea NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Urginea NOT All food No MRL NOT For use in homeo­ NO ENTRY maritima APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only. For oral use only. 02010R0037 — EN — 29.09.2018 — 035.001 — 76

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Uridine and its NOT All food No MRL NOT NO ENTRY NO ENTRY 5’-mono-5’-di- APPLICABLE producing required APPLICABLE and 5’-triphos­ species phates

Urticae herba NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Valine NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

▼M1

Valnemulin Valnemulin Porcine, 50 μg/kg Muscle NO ENTRY Anti-infectious rabbit 500 μg/kg Liver agents/Antibiotics 100 μg/kg Kidney

▼B

Vedaprofen Vedaprofen Equidae 50 μg/kg Muscle NO ENTRY Anti-inflammatory 20 μg/kg Fat agents/Nonsteroidal 100 μg/kg Liver anti-inflammatory 1 000 μg/kg Kidney agents

Vetrabutine NOT Porcine No MRL NOT NO ENTRY NO ENTRY hydrochloride APPLICABLE required APPLICABLE

Vincamine NOT Bovine No MRL NOT For use in newborn NO ENTRY APPLICABLE required APPLICABLE animals only.

▼M56

Virginiamycin Virginiamycin Poultry 10 μg/kg Muscle Not for use in Anti-infectious factor S1 30 μg/kg Skin and fat animals from which agents/Antibiotics 10 μg/kg Liver eggs are produced 60 μg/kg Kidney for human consumption

▼B

Virola sebifera NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only. 02010R0037 — EN — 29.09.2018 — 035.001 — 77

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Viscum album NOT All food No MRL NOT For use in homeo­ NO ENTRY APPLICABLE producing required APPLICABLE pathic veterinary species medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only.

Vitamin A NOT All food-pro­ No MRL NOT NO ENTRY NO ENTRY APPLICABLE ducing required APPLICABLE species

Vitamin B1 NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Vitamin B2 NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Vitamin B3 NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Vitamin B5 NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Vitamin B6 NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Vitamin B12 NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Vitamin D NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Vitamin E NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Wool alcohols NOT All food No MRL NOT For topical use only. NO ENTRY APPLICABLE producing required APPLICABLE species

Xylazine hydro­ NOT Bovine, No MRL NOT NO ENTRY NO ENTRY chloride APPLICABLE Equidae required APPLICABLE 02010R0037 — EN — 29.09.2018 — 035.001 — 78

▼B

Other Provisions (according to Pharmacologically Therapeutic Marker residue Animal Species MRL Target Tissues Article 14(7) of active Substance Classification Regulation (EC) No 470/2009)

Zinc acetate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Zinc aspartate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Zinc chloride NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Zinc gluconate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Zinc oleate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Zinc oxide NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Zinc stearate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species

Zinc sulphate NOT All food No MRL NOT NO ENTRY NO ENTRY APPLICABLE producing required APPLICABLE species 02010R0037 — EN — 29.09.2018 — 035.001 — 79

▼B Table 2

Prohibited substances

Pharmacologically active substance MRL

Aristolochia spp. and preparations thereof MRL cannot be established

Chloramphenicol MRL cannot be established

▼M32 ______

▼B

Chlorpromazine MRL cannot be established

Colchicine MRL cannot be established

Dapsone MRL cannot be established

Dimetridazole MRL cannot be established

Metronidazole MRL cannot be established

Nitrofurans (including furazolidone) MRL cannot be established

Ronidazole MRL cannot be established